Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
MAC.MDM.complement_resolving: Meta traits — page 4
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 1,931 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 3,001–4,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 3001 | Eyelid, lacrimal and orbital disorder | OPHTH000016 | 1.19 | Ophthalmic | Myeloid | — | 3 | 9 | 18 | |
| 3002 | Anaemia | HEMAT000001 | 1.19 | Hematologic | Myeloid | 22 | 1 | 6 | 5 | |
| 3003 | CCL16 levels | PROLV000282 | 1.19 | Protein levels | Hepatocyte | 117 | 2 | 8 | 16 | |
| 3004 | Prospective memory | PSYCH000009 | 1.19 | Psychiatric | Neural / glial | 18 | 4 | 13 | 19 | |
| 3005 | Temporomandibular joint disorder | MSKEL000022 | 1.19 | Musculoskeletal | Neural / glial | 0 | 1 | 6 | 11 | |
| 3006 | KLK8/LY6D ratio | PRORT001411 | 1.19 | Protein ratios | Cutaneous epithelium | 4 | 0 | 6 | 2 | |
| 3007 | Sleep apnoea | RESPI000035 | 1.19 | Respiratory | Neural / glial | 73 | 1 | 2 | 10 | |
| 3008 | ABHD14B levels | PROLV000005 | 1.19 | Protein levels | Myeloid | 12 | 3 | 5 | 17 | |
| 3009 | RAB2B levels | PROLV001698 | 1.18 | Protein levels | Stromal / connective | 1 | 3 | 4 | 9 | |
| 3010 | Dietary pattern | DTSUP000007 | 1.18 | Diet and Supplement | Neural / glial | 279 | 3 | 7 | 16 | |
| 3011 | APOF levels | PROLV000125 | 1.18 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 3012 | DAB2 levels | PROLV000591 | 1.18 | Protein levels | Lymphocyte | 6 | 3 | 7 | 19 | |
| 3013 | APP/LAMA4 ratio | PRORT000127 | 1.18 | Protein ratios | Lymphocyte | 7 | 3 | 9 | 26 | |
| 3014 | BCR/GOPC ratio | PRORT000225 | 1.18 | Protein ratios | Hepatocyte | 4 | 3 | 10 | 33 | |
| 3015 | Medication, cardiovascular | VASCU000036 | 1.18 | Vascular | Neural / glial | 11 | 2 | 4 | 16 | |
| 3016 | CD209/ITGAV ratio | PRORT000398 | 1.17 | Protein ratios | Neural / glial | 2 | 1 | 2 | 7 | |
| 3017 | BCL2L2 levels | PROLV000189 | 1.17 | Protein levels | Vascular | 0 | 2 | 5 | 9 | |
| 3018 | RAB31 levels | PROLV001699 | 1.17 | Protein levels | Lymphocyte | 0 | 3 | 6 | 14 | |
| 3019 | FXYD5/TMSB10 ratio | PRORT001196 | 1.17 | Protein ratios | Muscle / cardiac | 6 | 3 | 6 | 18 | |
| 3020 | SNAP29 levels | PROLV001907 | 1.17 | Protein levels | Platelet | 27 | 2 | 5 | 16 | |
| 3021 | Duodenal ulcer | GASTR000047 | 1.17 | Gastrointestinal | Vascular | 27 | 0 | 4 | 4 | |
| 3022 | ARSA/GUSB ratio | PRORT000143 | 1.17 | Protein ratios | Hepatocyte | 21 | 4 | 9 | 26 | |
| 3023 | GZMA/LTA ratio | PRORT001260 | 1.17 | Protein ratios | Lymphocyte | 33 | 3 | 11 | 34 | |
| 3024 | Bone marrow fat fraction, femur | MSKEL000001 | 1.17 | Musculoskeletal | Adipose | 27 | 3 | 8 | 14 | |
| 3025 | RGMA/RGMB ratio | PRORT001736 | 1.17 | Protein ratios | Muscle / cardiac | 14 | 1 | 5 | 12 | |
| 3026 | Atrial fibrillation and flutter | CARDI000019 | 1.17 | Cardiac | Muscle / cardiac | 758 | 2 | 4 | 8 | |
| 3027 | RBFOX3 levels | PROLV001708 | 1.17 | Protein levels | Lymphocyte | 0 | 2 | 16 | 35 | |
| 3028 | NPHS2 levels | PROLV001422 | 1.16 | Protein levels | B / plasma cell | 1 | 0 | 3 | 7 | |
| 3029 | LAYN/VWC2 ratio | PRORT001436 | 1.16 | Protein ratios | Hepatocyte | 3 | 3 | 10 | 17 | |
| 3030 | LAYN/PTPRN2 ratio | PRORT001433 | 1.16 | Protein ratios | Neural / glial | 5 | 2 | 13 | 28 | |
| 3031 | IRAG2/TBC1D23 ratio | PRORT001367 | 1.16 | Protein ratios | Hepatocyte | 1 | 2 | 9 | 19 | |
| 3032 | AAMDC levels | PROLV000004 | 1.16 | Protein levels | Myeloid | 19 | 1 | 5 | 7 | |
| 3033 | Polyarthropathy | MSKEL000019 | 1.16 | Musculoskeletal | Lymphocyte | 65 | 2 | 13 | 23 | |
| 3034 | MPI levels | PROLV001334 | 1.16 | Protein levels | Stromal / connective | 10 | 5 | 10 | 15 | |
| 3035 | ICAM3 levels | PROLV001006 | 1.15 | Protein levels | B / plasma cell | 143 | 2 | 12 | 18 | |
| 3036 | BAG3 levels | PROLV000174 | 1.15 | Protein levels | Hepatocyte | 73 | 1 | 4 | 12 | |
| 3037 | Medication, chronic lung disease | RESPI000006 | 1.15 | Respiratory | Neural / glial | 4 | 3 | 21 | 50 | |
| 3038 | UBXN1 levels | PROLV002134 | 1.15 | Protein levels | Lymphocyte | 5 | 4 | 15 | 38 | |
| 3039 | DYNLL1 levels | PROLV000666 | 1.15 | Protein levels | B / plasma cell | 0 | 1 | 4 | 4 | |
| 3040 | ANPEP levels | PROLV000103 | 1.15 | Protein levels | Hepatocyte | 62 | 1 | 8 | 18 | |
| 3041 | MESD/VASH1 ratio | PRORT001518 | 1.15 | Protein ratios | Adipose | 9 | 4 | 9 | 19 | |
| 3042 | CIAPIN1 levels | PROLV000435 | 1.15 | Protein levels | Lymphocyte | 1 | 5 | 9 | 35 | |
| 3043 | ALOX15B levels | PROLV000081 | 1.14 | Protein levels | Lymphocyte | 0 | 6 | 11 | 37 | |
| 3044 | Consultant specialty, general surgery | MISCL000017 | 1.14 | Miscellaneous | Neural / glial | 3 | 2 | 4 | 10 | |
| 3045 | DECR1/STX8 ratio | PRORT000884 | 1.14 | Protein ratios | Hepatocyte | 9 | 2 | 8 | 15 | |
| 3046 | ITGB1/MCAM ratio | PRORT001377 | 1.14 | Protein ratios | Vascular | 36 | 3 | 9 | 9 | |
| 3047 | Fasciitis | MSKEL000063 | 1.14 | Musculoskeletal | Stromal / connective | 16 | 1 | 3 | 8 | |
| 3048 | GRAP2/SNX9 ratio | PRORT001245 | 1.14 | Protein ratios | Hepatocyte | 6 | 4 | 7 | 27 | |
| 3049 | CYTL1 levels | PROLV000589 | 1.14 | Protein levels | Stromal / connective | 2 | 2 | 4 | 6 | |
| 3050 | AXIN1/INPPL1 ratio | PRORT000172 | 1.14 | Protein ratios | Granulosa cell | 1 | 3 | 9 | 11 | |
| 3051 | SMAD1 levels | PROLV001894 | 1.13 | Protein levels | Stromal / connective | 1 | 2 | 8 | 11 | |
| 3052 | HSBP1 levels | PROLV000992 | 1.13 | Protein levels | Muscle / cardiac | 19 | 7 | 10 | 27 | |
| 3053 | DOK2 levels | PROLV000642 | 1.13 | Protein levels | Platelet | 24 | 4 | 9 | 11 | |
| 3054 | Spondyloarthritis | IMMUN000044 | 1.13 | Immunologic | Myeloid | 110 | 4 | 8 | 20 | |
| 3055 | IL18BP levels | PROLV001055 | 1.13 | Protein levels | Granulosa cell | 31 | 0 | 9 | 14 | |
| 3056 | CASP8 levels | PROLV000270 | 1.13 | Protein levels | Vascular | 5 | 5 | 11 | 33 | |
| 3057 | EPS8L2/LGALS4 ratio | PRORT001041 | 1.13 | Protein ratios | Hepatocyte | 22 | 1 | 7 | 5 | |
| 3058 | NUCB2/TXNDC5 ratio | PRORT001608 | 1.13 | Protein ratios | Hepatocyte | 4 | 3 | 8 | 13 | |
| 3059 | PSMG3 levels | PROLV001660 | 1.13 | Protein levels | Muscle / cardiac | 21 | 3 | 10 | 24 | |
| 3060 | AK2 levels | PROLV000071 | 1.13 | Protein levels | Myeloid | 13 | 2 | 5 | 16 | |
| 3061 | Alcohol use | PSYCH000043 | 1.13 | Psychiatric | Neural / glial | 16 | 4 | 8 | 13 | |
| 3062 | PLA2G4A/PPP1R12A ratio | PRORT001673 | 1.13 | Protein ratios | Hepatocyte | 3 | 4 | 10 | 25 | |
| 3063 | Cutaneous and subcutaneous lipoma | DERMA000001 | 1.12 | Dermatologic | Lymphocyte | 0 | 3 | 13 | 26 | |
| 3064 | NECTIN2/NPDC1 ratio | PRORT001577 | 1.12 | Protein ratios | Vascular | 16 | 2 | 13 | 18 | |
| 3065 | AP1G2 levels | PROLV000110 | 1.12 | Protein levels | Stromal / connective | 14 | 2 | 5 | 12 | |
| 3066 | CRTAM/VCAM1 ratio | PRORT000775 | 1.12 | Protein ratios | Lymphocyte | 13 | 2 | 15 | 27 | |
| 3067 | IDUA levels | PROLV001013 | 1.12 | Protein levels | Hepatocyte | 160 | 1 | 6 | 10 | |
| 3068 | IGSF8/NECTIN2 ratio | PRORT001339 | 1.12 | Protein ratios | Granulosa cell | 15 | 1 | 14 | 37 | |
| 3069 | MOG levels | PROLV001332 | 1.12 | Protein levels | Pancreatic epithelium | 7 | 0 | 6 | 13 | |
| 3070 | AKT3 levels | PROLV000076 | 1.12 | Protein levels | Platelet | 10 | 5 | 10 | 16 | |
| 3071 | BTN2A1/IL18BP ratio | PRORT000257 | 1.11 | Protein ratios | Myeloid | 15 | 2 | 12 | 8 | |
| 3072 | Insulin levels | METBL000040 | 1.11 | Metabolic | Hepatocyte | 83 | 1 | 4 | 8 | |
| 3073 | RSPO3 levels | PROLV001759 | 1.11 | Protein levels | Muscle / cardiac | 0 | 4 | 9 | 25 | |
| 3074 | CALCOCO1 levels | PROLV000257 | 1.10 | Protein levels | Vascular | 7 | 1 | 2 | 13 | |
| 3075 | ANPEP/NT5E ratio | PRORT000102 | 1.10 | Protein ratios | Vascular | 19 | 0 | 4 | 9 | |
| 3076 | HTRA2/SNAP29 ratio | PRORT001312 | 1.10 | Protein ratios | Hepatocyte | 1 | 1 | 9 | 15 | |
| 3077 | FCRL2/SEMA7A ratio | PRORT001131 | 1.10 | Protein ratios | B / plasma cell | 15 | 1 | 8 | 26 | |
| 3078 | Glycerophosphocholines | LIPID000053 | 1.10 | Lipids | Neural / glial | 0 | 2 | 11 | 17 | |
| 3079 | Viral seropositivity | IMMUN000078 | 1.10 | Immunologic | Hepatocyte | 0 | 1 | 6 | 22 | |
| 3080 | Skin eruption | DERMA000027 | 1.10 | Dermatologic | Lymphocyte | 0 | 2 | 14 | 20 | |
| 3081 | DOK2/FADD ratio | PRORT000937 | 1.10 | Protein ratios | Hepatocyte | 12 | 2 | 5 | 12 | |
| 3082 | CNTNAP4 levels | PROLV000481 | 1.10 | Protein levels | Lymphocyte | 38 | 0 | 7 | 16 | |
| 3083 | CD46/THBD ratio | PRORT000460 | 1.10 | Protein ratios | Vascular | 20 | 2 | 8 | 18 | |
| 3084 | RNASEH2A levels | PROLV001741 | 1.09 | Protein levels | Neural / glial | 5 | 3 | 11 | 24 | |
| 3085 | CETN2/TDRKH ratio | PRORT000608 | 1.09 | Protein ratios | Myeloid | 0 | 2 | 5 | 12 | |
| 3086 | STX8/USP8 ratio | PRORT001821 | 1.09 | Protein ratios | Hepatocyte | 0 | 2 | 7 | 11 | |
| 3087 | Immune cell marker, CD8 T cell | HEMAT000023 | 1.09 | Hematologic | Lymphocyte | 17 | 2 | 18 | 40 | |
| 3088 | IDS levels | PROLV001012 | 1.09 | Protein levels | B / plasma cell | 11 | 2 | 5 | 9 | |
| 3089 | Mental disorder | PSYCH000013 | 1.09 | Psychiatric | Neural / glial | 21 | 2 | 9 | 20 | |
| 3090 | DAPP1/ITGB1BP2 ratio | PRORT000854 | 1.09 | Protein ratios | Myeloid | 21 | 5 | 19 | 31 | |
| 3091 | CA13 levels | PROLV000242 | 1.08 | Protein levels | Platelet | 19 | 3 | 4 | 16 | |
| 3092 | PHACTR2 levels | PROLV001549 | 1.08 | Protein levels | Myeloid | 24 | 2 | 5 | 13 | |
| 3093 | MYOM2 levels | PROLV001364 | 1.08 | Protein levels | Muscle / cardiac | 0 | 3 | 5 | 9 | |
| 3094 | NUDT2 levels | PROLV001454 | 1.08 | Protein levels | Myeloid | 0 | 2 | 7 | 10 | |
| 3095 | Reticulocyte | HEMAT000013 | 1.08 | Hematologic | Platelet | 1,657 | 4 | 2 | 9 | |
| 3096 | DOK2/LACTB2 ratio | PRORT000939 | 1.08 | Protein ratios | Hepatocyte | 2 | 2 | 6 | 11 | |
| 3097 | CD27/NECTIN4 ratio | PRORT000416 | 1.08 | Protein ratios | Lymphocyte | 15 | 2 | 13 | 34 | |
| 3098 | MPI/TACC3 ratio | PRORT001556 | 1.08 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 6 | 5 | |
| 3099 | Wellbeing | PSYCH000056 | 1.07 | Psychiatric | Neural / glial | 2 | 2 | 8 | 17 | |
| 3100 | MUC16 levels | PROLV001352 | 1.07 | Protein levels | Vascular | 0 | 0 | 4 | 3 | |
| 3101 | ENO1 levels | PROLV000705 | 1.07 | Protein levels | Myeloid | 5 | 4 | 8 | 15 | |
| 3102 | NUBP1 levels | PROLV001450 | 1.06 | Protein levels | B / plasma cell | 26 | 1 | 8 | 16 | |
| 3103 | RNF43 levels | PROLV001747 | 1.06 | Protein levels | Melanocyte | 0 | 1 | 1 | 3 | |
| 3104 | Consultant specialty, cardiology | CARDI000037 | 1.06 | Cardiac | Vascular | 51 | 4 | 13 | 19 | |
| 3105 | REG1A levels | PROLV001717 | 1.06 | Protein levels | Pancreatic epithelium | 20 | 0 | 10 | 11 | |
| 3106 | IL10 levels | PROLV001042 | 1.06 | Protein levels | Lymphocyte | 50 | 1 | 13 | 25 | |
| 3107 | SEC31A levels | PROLV001801 | 1.05 | Protein levels | Stromal / connective | 9 | 2 | 6 | 23 | |
| 3108 | Leucine | METAB000025 | 1.05 | Metabolites | Hepatocyte | 24 | 3 | 8 | 21 | |
| 3109 | FABP1 levels | PROLV000751 | 1.05 | Protein levels | Neural / glial | 0 | 2 | 9 | 16 | |
| 3110 | Coronary revascularization | VASCU000059 | 1.05 | Vascular | Vascular | 384 | 4 | 9 | 25 | |
| 3111 | ACVRL1 levels | PROLV000018 | 1.05 | Protein levels | Hepatocyte | 42 | 1 | 5 | 13 | |
| 3112 | ATXN10/PRTFDC1 ratio | PRORT000162 | 1.05 | Protein ratios | Hepatocyte | 0 | 1 | 3 | 12 | |
| 3113 | FLT1/VEGFA ratio | PRORT001164 | 1.05 | Protein ratios | Muscle / cardiac | 9 | 2 | 6 | 11 | |
| 3114 | Polyamine metabolites | METAB000059 | 1.05 | Metabolites | Hepatocyte | 1 | 1 | 9 | 17 | |
| 3115 | CLEC4D/MANSC1 ratio | PRORT000656 | 1.05 | Protein ratios | Muscle / cardiac | 16 | 3 | 9 | 15 | |
| 3116 | CALCOCO1/INPPL1 ratio | PRORT000296 | 1.05 | Protein ratios | Granulosa cell | 0 | 2 | 11 | 25 | |
| 3117 | Tendinitis | MSKEL000070 | 1.04 | Musculoskeletal | Neural / glial | 0 | 1 | 3 | 9 | |
| 3118 | Degenerative skin disorder | DERMA000038 | 1.04 | Dermatologic | Lymphocyte | 127 | 3 | 13 | 22 | |
| 3119 | Gastritis and duodenitis | GASTR000049 | 1.04 | Gastrointestinal | Neural / glial | — | 2 | 7 | 5 | |
| 3120 | Cerebral aneurysm | VASCU000004 | 1.04 | Vascular | Vascular | 0 | 0 | 1 | 5 | |
| 3121 | RELT levels | PROLV001722 | 1.04 | Protein levels | Vascular | 6 | 0 | 5 | 8 | |
| 3122 | PTGDS levels | PROLV001664 | 1.04 | Protein levels | Renal epithelium | 59 | 0 | 9 | 11 | |
| 3123 | HGF/TNFSF14 ratio | PRORT001286 | 1.04 | Protein ratios | Hepatocyte | 19 | 5 | 14 | 27 | |
| 3124 | Erythrocyte | HEMAT000005 | 1.04 | Hematologic | Hematopoietic progenitor | 3,061 | 3 | 7 | 17 | |
| 3125 | FAM3B/FUT3_FUT5 ratio | PRORT001112 | 1.04 | Protein ratios | Hepatocyte | 18 | 2 | 10 | 19 | |
| 3126 | DPEP1 levels | PROLV000643 | 1.04 | Protein levels | Myeloid | 74 | 2 | 6 | 16 | |
| 3127 | TNFAIP8L2 levels | PROLV002056 | 1.03 | Protein levels | Myeloid | 23 | 3 | 8 | 13 | |
| 3128 | Circulatory disorder | VASCU000025 | 1.03 | Vascular | Neural / glial | 1 | 1 | 5 | 14 | |
| 3129 | ESAM/JAM2 ratio | PRORT001062 | 1.03 | Protein ratios | Vascular | 10 | 4 | 10 | 16 | |
| 3130 | DKK1/VEGFA ratio | PRORT000904 | 1.03 | Protein ratios | Hematopoietic progenitor | 10 | 3 | 3 | 10 | |
| 3131 | CRADD levels | PROLV000516 | 1.03 | Protein levels | Myeloid | 7 | 4 | 9 | 23 | |
| 3132 | Purine metabolites | METAB000062 | 1.03 | Metabolites | Hepatocyte | 3 | 1 | 5 | 13 | |
| 3133 | ATP5IF1/DECR1 ratio | PRORT000154 | 1.03 | Protein ratios | Myeloid | 9 | 1 | 5 | 8 | |
| 3134 | EIF4G1 levels | PROLV000698 | 1.03 | Protein levels | Myeloid | 7 | 4 | 7 | 17 | |
| 3135 | Residential stability | SOCIO000014 | 1.03 | Socioeconomic | Neural / glial | 3 | 4 | 7 | 9 | |
| 3136 | Hypertriglyceridaemia | METBL000023 | 1.03 | Metabolic | Hepatocyte | 117 | 1 | 5 | 20 | |
| 3137 | ICAM3/TNFRSF13B ratio | PRORT001329 | 1.03 | Protein ratios | B / plasma cell | 40 | 1 | 7 | 6 | |
| 3138 | ADAMTS16 levels | PROLV000033 | 1.03 | Protein levels | Myeloid | 3 | 1 | 2 | 10 | |
| 3139 | PCDHB15 levels | PROLV001509 | 1.03 | Protein levels | Vascular | 46 | 2 | 6 | 9 | |
| 3140 | TAX1BP1 levels | PROLV001994 | 1.03 | Protein levels | Myeloid | 8 | 2 | 5 | 19 | |
| 3141 | Angina pectoris | CARDI000039 | 1.02 | Cardiac | Vascular | 317 | 5 | 9 | 18 | |
| 3142 | Glutamine | METAB000021 | 1.02 | Metabolites | Hepatocyte | 401 | 2 | 9 | 18 | |
| 3143 | Keloid and scarring | DERMA000041 | 1.02 | Dermatologic | Muscle / cardiac | 17 | 2 | 3 | 19 | |
| 3144 | RBP2 levels | PROLV001711 | 1.02 | Protein levels | Neural / glial | 30 | 1 | 10 | 15 | |
| 3145 | ANGPTL1 levels | PROLV000095 | 1.02 | Protein levels | Hepatocyte | 101 | 1 | 5 | 8 | |
| 3146 | Subcortical volume | NIMAG000026 | 1.02 | Neuroimaging | Neural / glial | 6 | 0 | 0 | 0 | |
| 3147 | CRNN levels | PROLV000528 | 1.02 | Protein levels | Cutaneous epithelium | 11 | 1 | 8 | 10 | |
| 3148 | Non-cancer illness history | MISCL000030 | 1.02 | Miscellaneous | Lymphocyte | 34 | 2 | 11 | 17 | |
| 3149 | BLVRB/HAGH ratio | PRORT000241 | 1.01 | Protein ratios | Neural / glial | 22 | 2 | 7 | 8 | |
| 3150 | Cancer, Lip | MALIG000017 | 1.01 | Malignancy | Lymphocyte | 0 | 3 | 11 | 39 | |
| 3151 | White matter lesion volume | NIMAG000027 | 1.01 | Neuroimaging | Stromal / connective | 30 | 4 | 10 | 14 | |
| 3152 | EFNA4 levels | PROLV000682 | 1.01 | Protein levels | Lymphocyte | 16 | 1 | 9 | 21 | |
| 3153 | FCRL3 levels | PROLV000785 | 1.01 | Protein levels | Lymphocyte | 48 | 2 | 9 | 18 | |
| 3154 | Grain and bakery preference | DTSUP000013 | 1.01 | Diet and Supplement | Neural / glial | 49 | 4 | 9 | 22 | |
| 3155 | Physical activity, none | BEHAV000005 | 1.01 | Behavioural | Myeloid | 0 | 4 | 15 | 23 | |
| 3156 | GZMH levels | PROLV000949 | 1.01 | Protein levels | Lymphocyte | 95 | 2 | 13 | 29 | |
| 3157 | Medication, hypnotic or sedative | PSYCH000020 | 1.00 | Psychiatric | Neural / glial | 1 | 5 | 14 | 26 | |
| 3158 | Goitre | ENDOC000019 | 1.00 | Endocrine | Neural / glial | 28 | 0 | 1 | 8 | |
| 3159 | EFNA1 levels | PROLV000681 | 1.00 | Protein levels | Vascular | 45 | 2 | 11 | 22 | |
| 3160 | ADAMTS13 levels | PROLV000031 | 1.00 | Protein levels | Hepatocyte | 161 | 2 | 10 | 17 | |
| 3161 | GABARAPL1 levels | PROLV000844 | 1.00 | Protein levels | Hepatocyte | — | 2 | 8 | 14 | |
| 3162 | STX16 levels | PROLV001967 | 1.00 | Protein levels | Muscle / cardiac | 7 | 4 | 5 | 17 | |
| 3163 | Housing type | SOCIO000013 | 1.00 | Socioeconomic | Neural / glial | — | 7 | 14 | 22 | |
| 3164 | KCTD5 levels | PROLV001131 | 1.00 | Protein levels | Lymphocyte | 3 | 1 | 12 | 19 | |
| 3165 | Upper respiratory inflammation | RESPI000041 | 1.00 | Respiratory | Muscle / cardiac | 1 | 1 | 1 | 9 | |
| 3166 | ISLR2 levels | PROLV001101 | 1.00 | Protein levels | Granulosa cell | 65 | 4 | 11 | 16 | |
| 3167 | HEXIM1/NUB1 ratio | PRORT001279 | 0.99 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 11 | |
| 3168 | BLVRB/HBQ1 ratio | PRORT000242 | 0.99 | Protein ratios | Muscle / cardiac | 11 | 3 | 8 | 13 | |
| 3169 | ADHD | PSYCH000033 | 0.99 | Psychiatric | Hematopoietic progenitor | 15 | 3 | 3 | 9 | |
| 3170 | ENG/PEAR1 ratio | PRORT001019 | 0.99 | Protein ratios | Granulosa cell | 3 | 3 | 11 | 21 | |
| 3171 | Body fat percentage, sex interaction | BCOMP000002 | 0.99 | Body composition | Muscle / cardiac | 0 | 2 | 6 | 13 | |
| 3172 | NRSN1 levels | PROLV001436 | 0.99 | Protein levels | Lymphocyte | 0 | 2 | 14 | 32 | |
| 3173 | LY96 levels | PROLV001250 | 0.99 | Protein levels | B / plasma cell | 122 | 4 | 12 | 23 | |
| 3174 | PCDH17/TEK ratio | PRORT001627 | 0.98 | Protein ratios | Vascular | 19 | 2 | 7 | 8 | |
| 3175 | Cortical volume | NIMAG000022 | 0.98 | Neuroimaging | Stromal / connective | 22 | 0 | 0 | 0 | |
| 3176 | ITPR1 levels | PROLV001122 | 0.98 | Protein levels | Vascular | 20 | 3 | 13 | 25 | |
| 3177 | CASP1 levels | PROLV000265 | 0.98 | Protein levels | Myeloid | 55 | 2 | 10 | 18 | |
| 3178 | FABP2/LGALS4 ratio | PRORT001098 | 0.98 | Protein ratios | Hepatocyte | 25 | 1 | 9 | 13 | |
| 3179 | SERPINB6 levels | PROLV001825 | 0.98 | Protein levels | Muscle / cardiac | 5 | 5 | 10 | 23 | |
| 3180 | Memory function | PSYCH000007 | 0.98 | Psychiatric | Neural / glial | 45 | 1 | 6 | 10 | |
| 3181 | Spine surgery | MSKEL000051 | 0.97 | Musculoskeletal | Stromal / connective | 0 | 2 | 7 | 14 | |
| 3182 | SNX9/STIP1 ratio | PRORT001801 | 0.97 | Protein ratios | Vascular | 0 | 6 | 15 | 31 | |
| 3183 | COCH levels | PROLV000482 | 0.97 | Protein levels | Hematopoietic progenitor | 30 | 3 | 5 | 13 | |
| 3184 | MICB_MICA/TEK ratio | PRORT001533 | 0.97 | Protein ratios | Myeloid | 65 | 3 | 12 | 25 | |
| 3185 | CLMP/TGFBR2 ratio | PRORT000670 | 0.97 | Protein ratios | Adipose | 11 | 2 | 6 | 6 | |
| 3186 | Lactate | METAB000066 | 0.97 | Metabolites | Myeloid | 0 | 1 | 5 | 10 | |
| 3187 | Frailty, metabolic problems | METBL000011 | 0.97 | Metabolic | Lymphocyte | 3 | 4 | 17 | 37 | |
| 3188 | Medication, calcium channel blocker | VASCU000035 | 0.97 | Vascular | Vascular | 18 | 1 | 4 | 14 | |
| 3189 | MAN2B2 levels | PROLV001261 | 0.97 | Protein levels | Hepatocyte | 53 | 4 | 17 | 35 | |
| 3190 | BACH1/CD2AP ratio | PRORT000191 | 0.97 | Protein ratios | Hepatocyte | 17 | 2 | 14 | 35 | |
| 3191 | FOXO1/USP8 ratio | PRORT001177 | 0.96 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 33 | |
| 3192 | CALCOCO1/MAP3K5 ratio | PRORT000298 | 0.96 | Protein ratios | B / plasma cell | 0 | 4 | 13 | 30 | |
| 3193 | Gut microbial abundance, CAG-177 | GASTR000020 | 0.96 | Gastrointestinal | Salivary epithelium | 0 | 0 | 7 | 5 | |
| 3194 | FSTL3/LTBR ratio | PRORT001181 | 0.96 | Protein ratios | Vascular | 1 | 2 | 8 | 11 | |
| 3195 | PHOSPHO1 levels | PROLV001551 | 0.96 | Protein levels | Muscle / cardiac | 5 | 1 | 6 | 12 | |
| 3196 | Heme malignancy, Lymphoid | MALIG000043 | 0.96 | Malignancy | B / plasma cell | 44 | 3 | 15 | 27 | |
| 3197 | APP/CCL28 ratio | PRORT000121 | 0.96 | Protein ratios | Granulosa cell | 8 | 6 | 8 | 20 | |
| 3198 | FKBP4 levels | PROLV000809 | 0.95 | Protein levels | Lymphocyte | 2 | 5 | 15 | 40 | |
| 3199 | DSG4/FABP9 ratio | PRORT000956 | 0.95 | Protein ratios | Cutaneous epithelium | 6 | 0 | 5 | 7 | |
| 3200 | Brainstem volume | NIMAG000017 | 0.95 | Neuroimaging | Neural / glial | 10 | 3 | 5 | 15 | |
| 3201 | C1R levels | PROLV000227 | 0.95 | Protein levels | Hepatocyte | 0 | 4 | 15 | 29 | |
| 3202 | Fall risk | MSKEL000043 | 0.95 | Musculoskeletal | Stromal / connective | 1 | 0 | 5 | 10 | |
| 3203 | Worry | PSYCH000032 | 0.95 | Psychiatric | Neural / glial | 94 | 2 | 3 | 5 | |
| 3204 | PRKAB1 levels | PROLV001630 | 0.94 | Protein levels | Lymphocyte | 16 | 3 | 12 | 25 | |
| 3205 | USP8 levels | PROLV002146 | 0.94 | Protein levels | Platelet | 2 | 5 | 6 | 11 | |
| 3206 | PTPRN2/RTBDN ratio | PRORT001724 | 0.94 | Protein ratios | Neural / glial | 7 | 2 | 6 | 18 | |
| 3207 | TNFSF8 levels | PROLV002081 | 0.94 | Protein levels | Hepatocyte | 70 | 1 | 6 | 12 | |
| 3208 | CPPED1 levels | PROLV000508 | 0.94 | Protein levels | Muscle / cardiac | 0 | 3 | 7 | 12 | |
| 3209 | CD79B/FCRL2 ratio | PRORT000511 | 0.94 | Protein ratios | Stromal / connective | 17 | 2 | 7 | 12 | |
| 3210 | Estimated glomerular filtration rate, eGFR | NEPHR000021 | 0.94 | Nephrourologic | Hepatocyte | 2,909 | 2 | 8 | 10 | |
| 3211 | SPTLC1 levels | PROLV001941 | 0.94 | Protein levels | Myeloid | 0 | 1 | 7 | 15 | |
| 3212 | PTPN6 levels | PROLV001672 | 0.94 | Protein levels | Myeloid | 16 | 3 | 10 | 18 | |
| 3213 | PRDX3 levels | PROLV001625 | 0.93 | Protein levels | Myeloid | 11 | 2 | 7 | 12 | |
| 3214 | CKAP4/PGF ratio | PRORT000623 | 0.93 | Protein ratios | Hepatocyte | 35 | 2 | 8 | 18 | |
| 3215 | White blood cell disorder | HEMAT000019 | 0.93 | Hematologic | Lymphocyte | 2 | 3 | 10 | 35 | |
| 3216 | FOXO1/MAP4K5 ratio | PRORT001173 | 0.93 | Protein ratios | Lymphocyte | 0 | 3 | 12 | 41 | |
| 3217 | Migraine | NEURO000010 | 0.93 | Neurologic | Neural / glial | 16 | 0 | 1 | 5 | |
| 3218 | Lysophosphatidylinositols | LIPID000056 | 0.93 | Lipids | Hepatocyte | 3 | 2 | 5 | 20 | |
| 3219 | Frailty, general | MISCL000039 | 0.93 | Miscellaneous | Neural / glial | 20 | 4 | 7 | 19 | |
| 3220 | CREG1/GUSB ratio | PRORT000751 | 0.93 | Protein ratios | Hepatocyte | 40 | 2 | 12 | 14 | |
| 3221 | FCRL6/GZMA ratio | PRORT001137 | 0.92 | Protein ratios | Lymphocyte | 14 | 2 | 13 | 40 | |
| 3222 | Refractive errors | OPHTH000034 | 0.92 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 3223 | SH3GLB2 levels | PROLV001854 | 0.92 | Protein levels | Lymphocyte | 14 | 3 | 17 | 52 | |
| 3224 | REG1A/REG4 ratio | PRORT001730 | 0.92 | Protein ratios | Hepatocyte | 35 | 1 | 6 | 14 | |
| 3225 | SULT2A1 levels | PROLV001974 | 0.91 | Protein levels | Hepatocyte | 51 | 1 | 4 | 21 | |
| 3226 | Cancer, Urinary tract | MALIG000033 | 0.91 | Malignancy | Lymphocyte | 4 | 1 | 13 | 11 | |
| 3227 | Pregnancy complication, general | REPRO000029 | 0.91 | Reproductive | Hepatocyte | 3 | 2 | 6 | 12 | |
| 3228 | Family history, hypertension | VASCU000022 | 0.91 | Vascular | Hematopoietic progenitor | 2 | 0 | 1 | 5 | |
| 3229 | CA4/TGFBR2 ratio | PRORT000284 | 0.91 | Protein ratios | Vascular | 28 | 0 | 7 | 11 | |
| 3230 | CRYGD levels | PROLV000534 | 0.91 | Protein levels | Hematopoietic progenitor | 17 | 1 | 5 | 20 | |
| 3231 | CDH1 levels | PROLV000371 | 0.90 | Protein levels | Gastrointestinal epithelium | 18 | 0 | 10 | 5 | |
| 3232 | Immunoglobulin deficiency | IMMUN000049 | 0.90 | Immunologic | B / plasma cell | 4 | 2 | 3 | 11 | |
| 3233 | DLL1/NBL1 ratio | PRORT000916 | 0.90 | Protein ratios | Lymphocyte | 6 | 1 | 6 | 16 | |
| 3234 | Medication, antithrombotic | VASCU000033 | 0.89 | Vascular | Vascular | 37 | 4 | 10 | 12 | |
| 3235 | EPHB6 levels | PROLV000720 | 0.89 | Protein levels | Hepatocyte | 28 | 2 | 6 | 10 | |
| 3236 | ROBO1/SPON1 ratio | PRORT001744 | 0.89 | Protein ratios | Vascular | 3 | 3 | 7 | 12 | |
| 3237 | HPCAL1 levels | PROLV000984 | 0.89 | Protein levels | Myeloid | 26 | 2 | 4 | 14 | |
| 3238 | SCT levels | PROLV001795 | 0.89 | Protein levels | Gastrointestinal epithelium | 1 | 0 | 6 | 10 | |
| 3239 | CPXM1/SPARC ratio | PRORT000736 | 0.89 | Protein ratios | Hematopoietic progenitor | 3 | 2 | 8 | 22 | |
| 3240 | AXIN1/ITGB1BP2 ratio | PRORT000173 | 0.89 | Protein ratios | Myeloid | 19 | 5 | 16 | 18 | |
| 3241 | IST1 levels | PROLV001103 | 0.89 | Protein levels | Myeloid | 20 | 2 | 4 | 15 | |
| 3242 | Myocardial infarction | CARDI000042 | 0.88 | Cardiac | Vascular | 343 | 3 | 9 | 12 | |
| 3243 | FEN1 levels | PROLV000789 | 0.88 | Protein levels | Neural / glial | 1 | 4 | 9 | 21 | |
| 3244 | EGFR/MEGF9 ratio | PRORT001001 | 0.88 | Protein ratios | Hepatocyte | 28 | 1 | 5 | 9 | |
| 3245 | AHSG levels | PROLV000065 | 0.88 | Protein levels | Hepatocyte | 49 | 2 | 9 | 25 | |
| 3246 | ANXA4/HSPB1 ratio | PRORT000111 | 0.88 | Protein ratios | Muscle / cardiac | 1 | 2 | 4 | 13 | |
| 3247 | CRACR2A/DNMBP ratio | PRORT000739 | 0.88 | Protein ratios | Myeloid | 7 | 1 | 6 | 7 | |
| 3248 | Thyroid peroxidase antibodies | IMMUN000045 | 0.88 | Immunologic | Lymphocyte | 20 | 2 | 14 | 22 | |
| 3249 | Gangliosides | LIPID000068 | 0.88 | Lipids | Granulosa cell | 7 | 0 | 1 | 5 | |
| 3250 | Hippocampal volume | NIMAG000024 | 0.88 | Neuroimaging | Stromal / connective | 0 | 0 | 0 | 0 | |
| 3251 | DNAJB1 levels | PROLV000630 | 0.88 | Protein levels | Vascular | 17 | 3 | 7 | 28 | |
| 3252 | CLEC4D/HGF ratio | PRORT000655 | 0.88 | Protein ratios | Hepatocyte | 60 | 1 | 8 | 10 | |
| 3253 | IL1R2 levels | PROLV001061 | 0.88 | Protein levels | Hepatocyte | 116 | 3 | 9 | 15 | |
| 3254 | Latent factor, red cell | HEMAT000038 | 0.87 | Hematologic | Lymphocyte | 67 | 0 | 1 | 4 | |
| 3255 | NTN1 levels | PROLV001444 | 0.87 | Protein levels | B / plasma cell | 0 | 1 | 3 | 14 | |
| 3256 | Medication, anti-cancer | MALIG000048 | 0.87 | Malignancy | Epithelial | 9 | 0 | 5 | 9 | |
| 3257 | ERBIN/LYN ratio | PRORT001049 | 0.87 | Protein ratios | Lymphocyte | 8 | 2 | 14 | 21 | |
| 3258 | Bilirubin | HPBIL000017 | 0.87 | Hepatopancreatobiliary | Hepatocyte | 448 | 2 | 7 | 17 | |
| 3259 | RRM2B levels | PROLV001757 | 0.87 | Protein levels | Myeloid | 1 | 3 | 8 | 10 | |
| 3260 | PTGES2 levels | PROLV001665 | 0.87 | Protein levels | Myeloid | 1 | 3 | 13 | 21 | |
| 3261 | GRP levels | PROLV000934 | 0.87 | Protein levels | Granulosa cell | 6 | 2 | 3 | 7 | |
| 3262 | EGLN1/PIK3AP1 ratio | PRORT001004 | 0.86 | Protein ratios | Myeloid | 2 | 2 | 6 | 9 | |
| 3263 | MITD1 levels | PROLV001318 | 0.86 | Protein levels | Stromal / connective | 0 | 4 | 8 | 20 | |
| 3264 | PDGFB/TNFSF13 ratio | PRORT001649 | 0.86 | Protein ratios | Neural / glial | 1 | 5 | 15 | 31 | |
| 3265 | CD40LG/SERPINE1 ratio | PRORT000453 | 0.86 | Protein ratios | Hematopoietic progenitor | 2 | 2 | 9 | 18 | |
| 3266 | ECG morphology, adjusted | ECGRM000001 | 0.86 | Electrocardiogram | Muscle / cardiac | 426 | 2 | 3 | 9 | |
| 3267 | TJAP1 levels | PROLV002043 | 0.86 | Protein levels | Stromal / connective | 1 | 2 | 5 | 14 | |
| 3268 | Skin elastin | DERMA000042 | 0.86 | Dermatologic | Neural / glial | 0 | 4 | 5 | 19 | |
| 3269 | DSG3/NECTIN4 ratio | PRORT000954 | 0.86 | Protein ratios | Lymphocyte | 35 | 0 | 15 | 27 | |
| 3270 | FABP5 levels | PROLV000755 | 0.86 | Protein levels | Stromal / connective | 7 | 5 | 11 | 35 | |
| 3271 | Psoriasis | IMMUN000039 | 0.86 | Immunologic | Lymphocyte | 213 | 2 | 14 | 19 | |
| 3272 | Knee derangements | MSKEL000016 | 0.86 | Musculoskeletal | Stromal / connective | 5 | 1 | 2 | 7 | |
| 3273 | PDCD1/TNFRSF9 ratio | PRORT001631 | 0.86 | Protein ratios | Epithelial | 7 | 1 | 13 | 21 | |
| 3274 | LIPF levels | PROLV001216 | 0.85 | Protein levels | Epithelial | 5 | 0 | 1 | 2 | |
| 3275 | EIF4E levels | PROLV000696 | 0.85 | Protein levels | Myeloid | 5 | 3 | 10 | 16 | |
| 3276 | DLL1/NECTIN4 ratio | PRORT000917 | 0.85 | Protein ratios | Salivary epithelium | 2 | 0 | 7 | 9 | |
| 3277 | CASP3 levels | PROLV000268 | 0.85 | Protein levels | Platelet | 26 | 3 | 9 | 10 | |
| 3278 | RIDA levels | PROLV001733 | 0.85 | Protein levels | Hepatocyte | 51 | 3 | 17 | 29 | |
| 3279 | CD69 levels | PROLV000351 | 0.85 | Protein levels | Platelet | 17 | 3 | 4 | 13 | |
| 3280 | BAG6 levels | PROLV000175 | 0.85 | Protein levels | Muscle / cardiac | 0 | 2 | 6 | 15 | |
| 3281 | IL17D levels | PROLV001052 | 0.85 | Protein levels | Hepatocyte | 18 | 4 | 8 | 25 | |
| 3282 | ACOX1/VSIR ratio | PRORT000013 | 0.85 | Protein ratios | Myeloid | 16 | 1 | 6 | 12 | |
| 3283 | SRPK2 levels | PROLV001944 | 0.85 | Protein levels | Vascular | 3 | 3 | 9 | 32 | |
| 3284 | TDP1 levels | PROLV002007 | 0.85 | Protein levels | Epithelial | 13 | 0 | 3 | 9 | |
| 3285 | F11 levels | PROLV000741 | 0.84 | Protein levels | Hepatocyte | 103 | 3 | 8 | 13 | |
| 3286 | CC2D1A levels | PROLV000273 | 0.84 | Protein levels | Vascular | 0 | 4 | 8 | 27 | |
| 3287 | Methionine metabolites | METAB000010 | 0.84 | Metabolites | Granulosa cell | 1 | 2 | 7 | 19 | |
| 3288 | CA2/PSMG3 ratio | PRORT000277 | 0.84 | Protein ratios | Lymphocyte | 3 | 3 | 4 | 19 | |
| 3289 | APRT levels | PROLV000131 | 0.84 | Protein levels | Lymphocyte | 4 | 3 | 7 | 36 | |
| 3290 | PAEP/RSPO1 ratio | PRORT001619 | 0.84 | Protein ratios | Stromal / connective | 1 | 0 | 7 | 9 | |
| 3291 | CLEC1A levels | PROLV000447 | 0.84 | Protein levels | Myeloid | 10 | 0 | 5 | 9 | |
| 3292 | Cough | RESPI000027 | 0.84 | Respiratory | Myeloid | 0 | 4 | 7 | 11 | |
| 3293 | LACTB2 levels | PROLV001174 | 0.84 | Protein levels | Platelet | 2 | 3 | 9 | 25 | |
| 3294 | SPINT2 levels | PROLV001933 | 0.83 | Protein levels | Lymphocyte | 39 | 3 | 7 | 18 | |
| 3295 | Hydrocele | REPRO000012 | 0.83 | Reproductive | Stromal / connective | 7 | 0 | 8 | 15 | |
| 3296 | Psoriatic arthritis | IMMUN000040 | 0.83 | Immunologic | Lymphocyte | 88 | 2 | 15 | 20 | |
| 3297 | Epicondylitis | MSKEL000062 | 0.83 | Musculoskeletal | Neural / glial | 0 | 4 | 7 | 18 | |
| 3298 | CD69/TXNDC5 ratio | PRORT000501 | 0.83 | Protein ratios | Vascular | 1 | 2 | 10 | 13 | |
| 3299 | Weight-to-muscle ratio | BCOMP000010 | 0.83 | Body composition | Neural / glial | 1 | 5 | 8 | 19 | |
| 3300 | Breast size | BMORP000007 | 0.83 | Body morphology | Hepatocyte | 0 | 1 | 4 | 14 | |
| 3301 | AGXT/MME ratio | PRORT000053 | 0.83 | Protein ratios | Hepatocyte | 47 | 1 | 4 | 11 | |
| 3302 | Hip joint morphology | MSKEL000023 | 0.83 | Musculoskeletal | Stromal / connective | 56 | 2 | 4 | 7 | |
| 3303 | PROC levels | PROLV001637 | 0.83 | Protein levels | Hepatocyte | 164 | 2 | 6 | 14 | |
| 3304 | Cancer, Melanoma | MALIG000020 | 0.83 | Malignancy | Lymphocyte | 121 | 2 | 5 | 25 | |
| 3305 | ERBB2/GUSB ratio | PRORT001043 | 0.83 | Protein ratios | Hepatocyte | 25 | 3 | 13 | 29 | |
| 3306 | STAMBP levels | PROLV001957 | 0.83 | Protein levels | Vascular | 0 | 3 | 9 | 20 | |
| 3307 | CDH17/GALNT3 ratio | PRORT000548 | 0.82 | Protein ratios | Neural / glial | 1 | 1 | 8 | 8 | |
| 3308 | SVEP1 levels | PROLV001982 | 0.82 | Protein levels | Vascular | 7 | 2 | 7 | 4 | |
| 3309 | MINDY1 levels | PROLV001315 | 0.82 | Protein levels | Stromal / connective | 8 | 3 | 5 | 11 | |
| 3310 | Hyperparathyroidism | ENDOC000004 | 0.82 | Endocrine | Hepatocyte | 0 | 3 | 8 | 17 | |
| 3311 | Exercise workload | CARDI000024 | 0.82 | Cardiac | Neural / glial | 0 | 5 | 11 | 28 | |
| 3312 | VPS53 levels | PROLV002168 | 0.82 | Protein levels | Vascular | 21 | 1 | 3 | 12 | |
| 3313 | CD46/NECTIN2 ratio | PRORT000456 | 0.82 | Protein ratios | Vascular | 26 | 3 | 7 | 16 | |
| 3314 | TBCA levels | PROLV001998 | 0.82 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 3315 | GGH/INHBC ratio | PRORT001212 | 0.81 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 25 | |
| 3316 | DAPP1/PTPN6 ratio | PRORT000856 | 0.81 | Protein ratios | Hepatocyte | 0 | 1 | 7 | 10 | |
| 3317 | Alcohol preference | PSYCH000042 | 0.81 | Psychiatric | Neural / glial | 14 | 4 | 10 | 11 | |
| 3318 | Medication, respiratory | RESPI000007 | 0.81 | Respiratory | Myeloid | 1 | 2 | 6 | 7 | |
| 3319 | CXCL16/NOTCH1 ratio | PRORT000822 | 0.81 | Protein ratios | Vascular | 15 | 3 | 15 | 44 | |
| 3320 | Coeliac disease | IMMUN000026 | 0.81 | Immunologic | Lymphocyte | 152 | 2 | 11 | 21 | |
| 3321 | Glucose levels | METBL000037 | 0.81 | Metabolic | Hepatocyte | 1,438 | 1 | 6 | 8 | |
| 3322 | AGR2 levels | PROLV000055 | 0.81 | Protein levels | Pancreatic epithelium | 26 | 0 | 8 | 13 | |
| 3323 | VEGFC/ZBTB16 ratio | PRORT001859 | 0.81 | Protein ratios | Muscle / cardiac | 10 | 4 | 9 | 26 | |
| 3324 | Brain neuroimaging feature | NIMAG000005 | 0.81 | Neuroimaging | Stromal / connective | 137 | 0 | 2 | 9 | |
| 3325 | PLIN3 levels | PROLV001579 | 0.81 | Protein levels | Muscle / cardiac | 0 | 6 | 11 | 22 | |
| 3326 | Central serous chorioretinopathy | OPHTH000035 | 0.81 | Ophthalmic | Hepatocyte | 11 | 2 | 5 | 15 | |
| 3327 | RWDD1 levels | PROLV001765 | 0.81 | Protein levels | Vascular | 15 | 3 | 7 | 24 | |
| 3328 | Aortic aneurysm | VASCU000002 | 0.81 | Vascular | Vascular | 163 | 5 | 11 | 20 | |
| 3329 | DRG2 levels | PROLV000652 | 0.81 | Protein levels | Lymphocyte | 1 | 3 | 7 | 30 | |
| 3330 | DBNL/HEXIM1 ratio | PRORT000866 | 0.80 | Protein ratios | Muscle / cardiac | 0 | 2 | 8 | 15 | |
| 3331 | CD160/CXCL16 ratio | PRORT000376 | 0.80 | Protein ratios | Lymphocyte | 12 | 2 | 13 | 32 | |
| 3332 | Monoclonal gammopathy | HEMAT000041 | 0.80 | Hematologic | B / plasma cell | 2 | 4 | 15 | 28 | |
| 3333 | VAV3 levels | PROLV002154 | 0.80 | Protein levels | Myeloid | 23 | 4 | 5 | 11 | |
| 3334 | TBCC levels | PROLV002000 | 0.80 | Protein levels | Myeloid | 7 | 4 | 8 | 11 | |
| 3335 | GPR15L levels | PROLV000928 | 0.80 | Protein levels | Cutaneous epithelium | 1 | 0 | 11 | 13 | |
| 3336 | COLEC12 levels | PROLV000494 | 0.80 | Protein levels | Stromal / connective | 9 | 1 | 4 | 6 | |
| 3337 | CCER2 levels | PROLV000277 | 0.79 | Protein levels | Muscle / cardiac | 19 | 2 | 6 | 8 | |
| 3338 | Episcleritis | OPHTH000004 | 0.79 | Ophthalmic | Muscle / cardiac | 0 | 2 | 7 | 14 | |
| 3339 | Medication, anti-asthmatic | IMMUN000082 | 0.79 | Immunologic | Lymphocyte | 36 | 1 | 8 | 22 | |
| 3340 | MANF/SNX9 ratio | PRORT001481 | 0.79 | Protein ratios | Muscle / cardiac | 0 | 2 | 10 | 23 | |
| 3341 | DLL1/NOTCH1 ratio | PRORT000918 | 0.79 | Protein ratios | Vascular | 8 | 0 | 6 | 11 | |
| 3342 | PROS1 levels | PROLV001640 | 0.78 | Protein levels | Hepatocyte | 37 | 1 | 6 | 9 | |
| 3343 | IGFBP1 levels | PROLV001028 | 0.78 | Protein levels | Hepatocyte | 15 | 1 | 7 | 11 | |
| 3344 | SIGLEC9 levels | PROLV001865 | 0.78 | Protein levels | Hepatocyte | 118 | 1 | 6 | 11 | |
| 3345 | EIF2AK2 levels | PROLV000693 | 0.78 | Protein levels | Myeloid | 3 | 2 | 8 | 17 | |
| 3346 | ITGB1/TFPI ratio | PRORT001381 | 0.78 | Protein ratios | Hepatocyte | 52 | 1 | 14 | 13 | |
| 3347 | MSTN/RGMA ratio | PRORT001564 | 0.78 | Protein ratios | Muscle / cardiac | 12 | 2 | 12 | 27 | |
| 3348 | HSPG2/IGFBP6 ratio | PRORT001307 | 0.78 | Protein ratios | Adipose | 15 | 3 | 9 | 18 | |
| 3349 | SRC levels | PROLV001942 | 0.78 | Protein levels | Platelet | 9 | 5 | 8 | 15 | |
| 3350 | KRT8 levels | PROLV001168 | 0.78 | Protein levels | Adipose | 0 | 0 | 3 | 3 | |
| 3351 | CA12 levels | PROLV000241 | 0.78 | Protein levels | Epithelial | 95 | 0 | 8 | 7 | |
| 3352 | CA1/CA2 ratio | PRORT000267 | 0.78 | Protein ratios | Muscle / cardiac | 0 | 1 | 7 | 11 | |
| 3353 | Neurological disorder | NEURO000008 | 0.78 | Neurologic | Muscle / cardiac | 0 | 1 | 7 | 7 | |
| 3354 | Arterial thrombosis | VASCU000005 | 0.77 | Vascular | Vascular | 0 | 0 | 7 | 21 | |
| 3355 | DBI levels | PROLV000597 | 0.77 | Protein levels | Stromal / connective | 31 | 5 | 10 | 18 | |
| 3356 | Ataxia | NEURO000013 | 0.77 | Neurologic | Neural / glial | 0 | 3 | 9 | 22 | |
| 3357 | EFEMP1/FSTL3 ratio | PRORT000986 | 0.77 | Protein ratios | Stromal / connective | 14 | 4 | 6 | 20 | |
| 3358 | FGF19/SCG2 ratio | PRORT001139 | 0.77 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 13 | |
| 3359 | Study participation | BEHAV000004 | 0.77 | Behavioural | Neural / glial | 41 | 3 | 10 | 26 | |
| 3360 | TRIM5 levels | PROLV002110 | 0.77 | Protein levels | Hepatocyte | 9 | 2 | 12 | 30 | |
| 3361 | Dihydrosphingomyelins | LIPID000067 | 0.77 | Lipids | Epithelial | 0 | 0 | 6 | 10 | |
| 3362 | LUZP2 levels | PROLV001245 | 0.76 | Protein levels | Granulosa cell | 0 | 1 | 4 | 8 | |
| 3363 | TRAF2/WWP2 ratio | PRORT001857 | 0.76 | Protein ratios | Lymphocyte | 1 | 3 | 18 | 51 | |
| 3364 | Gut microbial abundance, Lawsonibacter | GASTR000027 | 0.76 | Gastrointestinal | Neural / glial | 0 | 1 | 3 | 6 | |
| 3365 | AHCY/HSPA1A ratio | PRORT000055 | 0.76 | Protein ratios | Lymphocyte | 10 | 3 | 12 | 39 | |
| 3366 | TREML1 levels | PROLV002103 | 0.76 | Protein levels | Lymphocyte | 27 | 2 | 7 | 19 | |
| 3367 | COL6A3/COLEC12 ratio | PRORT000695 | 0.76 | Protein ratios | Adipose | 53 | 4 | 9 | 18 | |
| 3368 | NCR3LG1 levels | PROLV001384 | 0.76 | Protein levels | Hepatocyte | 32 | 1 | 8 | 15 | |
| 3369 | NELL1 levels | PROLV001390 | 0.76 | Protein levels | Renal epithelium | 16 | 0 | 8 | 22 | |
| 3370 | CD5 levels | PROLV000344 | 0.76 | Protein levels | Lymphocyte | 116 | 3 | 9 | 29 | |
| 3371 | Bowel function | GASTR000002 | 0.76 | Gastrointestinal | Neural / glial | 18 | 5 | 9 | 11 | |
| 3372 | LBP levels | PROLV001188 | 0.76 | Protein levels | Hepatocyte | 18 | 2 | 7 | 22 | |
| 3373 | Graves disease | IMMUN000027 | 0.76 | Immunologic | Lymphocyte | 94 | 1 | 11 | 18 | |
| 3374 | Reaction time | PSYCH000010 | 0.76 | Psychiatric | Neural / glial | 67 | 3 | 6 | 11 | |
| 3375 | KRT18 levels | PROLV001165 | 0.75 | Protein levels | Hepatocyte | 62 | 1 | 9 | 29 | |
| 3376 | PRSS22 levels | PROLV001645 | 0.75 | Protein levels | Renal epithelium | 38 | 0 | 3 | 6 | |
| 3377 | Brain functional connectivity | NIMAG000002 | 0.75 | Neuroimaging | Neural / glial | 0 | 0 | 0 | 0 | |
| 3378 | NUDT5 levels | PROLV001455 | 0.75 | Protein levels | Vascular | 0 | 4 | 8 | 15 | |
| 3379 | IMMT levels | PROLV001083 | 0.75 | Protein levels | Vascular | 0 | 0 | 6 | 20 | |
| 3380 | Thyrotoxicosis | ENDOC000024 | 0.75 | Endocrine | Lymphocyte | 91 | 1 | 11 | 19 | |
| 3381 | PRG2 levels | PROLV001628 | 0.75 | Protein levels | Lymphocyte | 70 | 4 | 8 | 35 | |
| 3382 | AXIN1/IKBKG ratio | PRORT000171 | 0.75 | Protein ratios | Muscle / cardiac | 10 | 5 | 13 | 29 | |
| 3383 | SPINK4 levels | PROLV001929 | 0.75 | Protein levels | Gastrointestinal epithelium | 25 | 0 | 6 | 11 | |
| 3384 | CGREF1/FAM3C ratio | PRORT000609 | 0.74 | Protein ratios | Hepatocyte | 2 | 0 | 4 | 8 | |
| 3385 | Negative affect | PSYCH000030 | 0.74 | Psychiatric | Neural / glial | 83 | 3 | 8 | 9 | |
| 3386 | Medication, antiplatelet | VASCU000032 | 0.74 | Vascular | Vascular | 78 | 1 | 5 | 9 | |
| 3387 | TDGF1 levels | PROLV002006 | 0.74 | Protein levels | Myeloid | 46 | 2 | 2 | 5 | |
| 3388 | ICA1 levels | PROLV001003 | 0.74 | Protein levels | Myeloid | 31 | 2 | 5 | 18 | |
| 3389 | ENO2/MANF ratio | PRORT001025 | 0.74 | Protein ratios | Muscle / cardiac | 1 | 2 | 6 | 15 | |
| 3390 | CEP85 levels | PROLV000403 | 0.73 | Protein levels | Lymphocyte | 9 | 2 | 11 | 30 | |
| 3391 | Medication, thyroid | ENDOC000002 | 0.73 | Endocrine | Lymphocyte | 202 | 1 | 13 | 19 | |
| 3392 | YAP1 levels | PROLV002202 | 0.73 | Protein levels | Granulosa cell | 3 | 0 | 5 | 20 | |
| 3393 | Gut microbial abundance, Flavonifractor | GASTR000025 | 0.73 | Gastrointestinal | Granulosa cell | 0 | 0 | 2 | 4 | |
| 3394 | Heart rate | CARDI000021 | 0.73 | Cardiac | Muscle / cardiac | 1,425 | 2 | 8 | 13 | |
| 3395 | Electronic device use | BEHAV000017 | 0.73 | Behavioural | Neural / glial | 29 | 3 | 8 | 21 | |
| 3396 | IMPACT levels | PROLV001085 | 0.73 | Protein levels | Muscle / cardiac | 1 | 5 | 11 | 38 | |
| 3397 | NTF3 levels | PROLV001442 | 0.73 | Protein levels | Vascular | 1 | 3 | 8 | 14 | |
| 3398 | CHCHD10 levels | PROLV000424 | 0.73 | Protein levels | Muscle / cardiac | 0 | 4 | 8 | 21 | |
| 3399 | CNPY4/ERBIN ratio | PRORT000679 | 0.73 | Protein ratios | Hepatocyte | 19 | 4 | 7 | 19 | |
| 3400 | Pulmonary fibrosis | RESPI000017 | 0.73 | Respiratory | Lymphocyte | 5 | 2 | 12 | 33 | |
| 3401 | CTSF/CTSV ratio | PRORT000800 | 0.73 | Protein ratios | Hepatocyte | 55 | 1 | 7 | 9 | |
| 3402 | ZNRF4 levels | PROLV002214 | 0.72 | Protein levels | Adipose | 7 | 5 | 11 | 14 | |
| 3403 | Vitamin C | METAB000077 | 0.72 | Metabolites | Lymphocyte | 4 | 2 | 10 | 33 | |
| 3404 | PECAM1 levels | PROLV001534 | 0.72 | Protein levels | Myeloid | 39 | 2 | 7 | 17 | |
| 3405 | JAM3 levels | PROLV001125 | 0.72 | Protein levels | Lymphocyte | 3 | 2 | 6 | 17 | |
| 3406 | Pregnancy termination | BEHAV000010 | 0.72 | Behavioural | Neural / glial | 0 | 6 | 9 | 19 | |
| 3407 | CD84/TREML2 ratio | PRORT000529 | 0.72 | Protein ratios | B / plasma cell | 3 | 2 | 4 | 10 | |
| 3408 | COLEC12/OGN ratio | PRORT000705 | 0.72 | Protein ratios | Stromal / connective | 12 | 3 | 11 | 19 | |
| 3409 | RWDD1/SUMF2 ratio | PRORT001752 | 0.72 | Protein ratios | Hepatocyte | 39 | 2 | 5 | 10 | |
| 3410 | ACRBP levels | PROLV000016 | 0.72 | Protein levels | Lymphocyte | 3 | 2 | 7 | 20 | |
| 3411 | Operation, hernia | GASTR000040 | 0.72 | Gastrointestinal | Adipose | 21 | 2 | 5 | 9 | |
| 3412 | CELA3A/PLA2G1B ratio | PRORT000598 | 0.71 | Protein ratios | Vascular | 34 | 1 | 5 | 11 | |
| 3413 | Xenobiotic metabolites | METAB000080 | 0.71 | Metabolites | Hepatocyte | 26 | 1 | 3 | 11 | |
| 3414 | Vitreous disorder | OPHTH000047 | 0.71 | Ophthalmic | Neural / glial | 1 | 2 | 6 | 7 | |
| 3415 | Pain, back | MSKEL000033 | 0.71 | Musculoskeletal | Neural / glial | 43 | 4 | 8 | 31 | |
| 3416 | MZB1/TNFRSF13B ratio | PRORT001568 | 0.71 | Protein ratios | B / plasma cell | 4 | 2 | 15 | 28 | |
| 3417 | Hypertension | VASCU000027 | 0.71 | Vascular | Vascular | 668 | 3 | 5 | 11 | |
| 3418 | FABP1/SULT2A1 ratio | PRORT001097 | 0.71 | Protein ratios | Hepatocyte | 10 | 4 | 8 | 18 | |
| 3419 | AFM levels | PROLV000052 | 0.71 | Protein levels | Hepatocyte | 24 | 1 | 7 | 20 | |
| 3420 | PIBF1 levels | PROLV001555 | 0.71 | Protein levels | Vascular | 7 | 1 | 5 | 11 | |
| 3421 | AHSP/BLVRB ratio | PRORT000056 | 0.70 | Protein ratios | Stromal / connective | 33 | 2 | 13 | 32 | |
| 3422 | GBP6 levels | PROLV000863 | 0.70 | Protein levels | Hepatocyte | 11 | 2 | 9 | 14 | |
| 3423 | Vehicle ownership | SOCIO000015 | 0.70 | Socioeconomic | Neural / glial | 2 | 4 | 8 | 18 | |
| 3424 | SCARA5/SCARF2 ratio | PRORT001758 | 0.70 | Protein ratios | Vascular | 4 | 1 | 3 | 18 | |
| 3425 | Cancer, Respiratory system | MALIG000027 | 0.70 | Malignancy | Lymphocyte | 4 | 3 | 12 | 38 | |
| 3426 | CCL17/PDGFB ratio | PRORT000346 | 0.70 | Protein ratios | Lymphocyte | 23 | 3 | 17 | 37 | |
| 3427 | Medication, anti-gout | METBL000025 | 0.70 | Metabolic | Hepatocyte | 167 | 1 | 4 | 9 | |
| 3428 | ALDH1A1/RBKS ratio | PRORT000080 | 0.70 | Protein ratios | Hematopoietic progenitor | 1 | 1 | 2 | 9 | |
| 3429 | Snoring | RESPI000036 | 0.70 | Respiratory | Neural / glial | 12 | 3 | 11 | 32 | |
| 3430 | PDGFB/ST6GAL1 ratio | PRORT001647 | 0.70 | Protein ratios | Neural / glial | 12 | 6 | 11 | 24 | |
| 3431 | Organic acid metabolites | METAB000067 | 0.70 | Metabolites | Pancreatic epithelium | 0 | 0 | 0 | 0 | |
| 3432 | GOLM2/STC1 ratio | PRORT001223 | 0.70 | Protein ratios | Vascular | 15 | 1 | 5 | 9 | |
| 3433 | MIF levels | PROLV001313 | 0.70 | Protein levels | Lymphocyte | 4 | 1 | 5 | 28 | |
| 3434 | CDH17/DSG2 ratio | PRORT000547 | 0.70 | Protein ratios | Lymphocyte | 8 | 0 | 3 | 8 | |
| 3435 | Cortical surface area | NIMAG000009 | 0.69 | Neuroimaging | Neural / glial | 78 | 0 | 0 | 0 | |
| 3436 | Acquired foot deformities | MSKEL000052 | 0.69 | Musculoskeletal | Stromal / connective | 38 | 2 | 5 | 12 | |
| 3437 | HGS levels | PROLV000967 | 0.69 | Protein levels | Stromal / connective | 0 | 3 | 11 | 17 | |
| 3438 | APEX1 levels | PROLV000114 | 0.69 | Protein levels | Muscle / cardiac | 6 | 4 | 12 | 38 | |
| 3439 | Personality disorder | PSYCH000035 | 0.69 | Psychiatric | Hepatocyte | 0 | 1 | 5 | 15 | |
| 3440 | PEAR1/SNAP23 ratio | PRORT001659 | 0.69 | Protein ratios | Neural / glial | 1 | 2 | 9 | 26 | |
| 3441 | SLPI levels | PROLV001892 | 0.69 | Protein levels | Cutaneous epithelium | 0 | 0 | 11 | 9 | |
| 3442 | Heme malignancy, Lymphoma | MALIG000044 | 0.69 | Malignancy | B / plasma cell | 27 | 2 | 6 | 28 | |
| 3443 | Malocclusion | DENTA000008 | 0.68 | Dental | Stromal / connective | 0 | 0 | 1 | 2 | |
| 3444 | CDHR2/MME ratio | PRORT000563 | 0.68 | Protein ratios | Hepatocyte | 52 | 1 | 8 | 7 | |
| 3445 | Educational attainment | SOCIO000002 | 0.68 | Socioeconomic | Neural / glial | 143 | 5 | 11 | 23 | |
| 3446 | F2R/SEMA4D ratio | PRORT001080 | 0.68 | Protein ratios | Muscle / cardiac | 0 | 4 | 10 | 15 | |
| 3447 | ATP5IF1/LYN ratio | PRORT000159 | 0.68 | Protein ratios | B / plasma cell | 1 | 3 | 18 | 33 | |
| 3448 | Birth complication | REPRO000036 | 0.68 | Reproductive | Muscle / cardiac | 0 | 0 | 7 | 16 | |
| 3449 | Drug hypersensitivity | IMMUN000006 | 0.68 | Immunologic | Lymphocyte | 23 | 4 | 14 | 32 | |
| 3450 | ECG morphology, unadjusted | ECGRM000002 | 0.68 | Electrocardiogram | Muscle / cardiac | 478 | 2 | 4 | 6 | |
| 3451 | AXIN1/MAVS ratio | PRORT000175 | 0.68 | Protein ratios | Neural / glial | 6 | 3 | 16 | 35 | |
| 3452 | NPDC1/TAFA5 ratio | PRORT001595 | 0.68 | Protein ratios | Vascular | 24 | 4 | 9 | 29 | |
| 3453 | NAGPA levels | PROLV001373 | 0.68 | Protein levels | Hepatocyte | 66 | 1 | 4 | 14 | |
| 3454 | AXIN1/DOK2 ratio | PRORT000168 | 0.68 | Protein ratios | Granulosa cell | 5 | 2 | 6 | 17 | |
| 3455 | SPON2 levels | PROLV001937 | 0.67 | Protein levels | Hepatocyte | 44 | 4 | 9 | 17 | |
| 3456 | FKBP5/MAP4K5 ratio | PRORT001157 | 0.67 | Protein ratios | Hepatocyte | 18 | 1 | 4 | 21 | |
| 3457 | RFC4 levels | PROLV001726 | 0.67 | Protein levels | Stromal / connective | 1 | 4 | 14 | 19 | |
| 3458 | IPCEF1 levels | PROLV001095 | 0.67 | Protein levels | Lymphocyte | 26 | 3 | 8 | 22 | |
| 3459 | CALCOCO1/IKBKG ratio | PRORT000295 | 0.67 | Protein ratios | Muscle / cardiac | 0 | 4 | 11 | 25 | |
| 3460 | CXCL5/PPIB ratio | PRORT000830 | 0.67 | Protein ratios | Platelet | 1 | 6 | 12 | 30 | |
| 3461 | Cancer, Other | MALIG000023 | 0.67 | Malignancy | B / plasma cell | 0 | 2 | 12 | 21 | |
| 3462 | GZMA/GZMB ratio | PRORT001257 | 0.67 | Protein ratios | Lymphocyte | 44 | 2 | 12 | 21 | |
| 3463 | Processing speed | PSYCH000008 | 0.67 | Psychiatric | Neural / glial | 65 | 4 | 10 | 18 | |
| 3464 | TRIM25 levels | PROLV002108 | 0.67 | Protein levels | Myeloid | 1 | 2 | 4 | 9 | |
| 3465 | STAT5B levels | PROLV001959 | 0.67 | Protein levels | Myeloid | 29 | 5 | 12 | 20 | |
| 3466 | Asthma | IMMUN000005 | 0.67 | Immunologic | Lymphocyte | 397 | 2 | 13 | 13 | |
| 3467 | Insulin resistance | METBL000041 | 0.66 | Metabolic | Hepatocyte | 4 | 1 | 5 | 10 | |
| 3468 | Osteopathy | MSKEL000008 | 0.66 | Musculoskeletal | Muscle / cardiac | 0 | 3 | 4 | 18 | |
| 3469 | LYN/TACC3 ratio | PRORT001473 | 0.66 | Protein ratios | B / plasma cell | 0 | 6 | 9 | 16 | |
| 3470 | SLITRK2 levels | PROLV001889 | 0.66 | Protein levels | Lymphocyte | 15 | 3 | 11 | 28 | |
| 3471 | PRTFDC1 levels | PROLV001649 | 0.66 | Protein levels | Platelet | 28 | 3 | 11 | 12 | |
| 3472 | CA2/UBAC1 ratio | PRORT000279 | 0.66 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 3473 | CD58/ERBB3 ratio | PRORT000472 | 0.66 | Protein ratios | Hepatocyte | 55 | 1 | 5 | 12 | |
| 3474 | MME/NT5E ratio | PRORT001540 | 0.66 | Protein ratios | Hepatocyte | 24 | 1 | 4 | 9 | |
| 3475 | Otitis externa | AUDIO000003 | 0.65 | Auditory | Muscle / cardiac | 0 | 3 | 6 | 17 | |
| 3476 | DPEP2 levels | PROLV000644 | 0.65 | Protein levels | Myeloid | 28 | 1 | 6 | 12 | |
| 3477 | Glomerular disease | NEPHR000006 | 0.65 | Nephrourologic | Adipose | 5 | 2 | 3 | 9 | |
| 3478 | CD40LG/GP6 ratio | PRORT000451 | 0.65 | Protein ratios | Myeloid | 0 | 1 | 6 | 11 | |
| 3479 | GET3 levels | PROLV000873 | 0.65 | Protein levels | B / plasma cell | 3 | 2 | 3 | 21 | |
| 3480 | BCAM/NOTCH1 ratio | PRORT000211 | 0.65 | Protein ratios | Hepatocyte | 27 | 2 | 10 | 10 | |
| 3481 | Acquired absence of organs | MISCL000027 | 0.65 | Miscellaneous | Neural / glial | 1 | 4 | 12 | 15 | |
| 3482 | PARK7 levels | PROLV001496 | 0.65 | Protein levels | Lymphocyte | 0 | 5 | 13 | 38 | |
| 3483 | Histidine | METAB000023 | 0.65 | Metabolites | Hepatocyte | 171 | 1 | 4 | 8 | |
| 3484 | Peripheral neuropathy | NEURO000032 | 0.65 | Neurologic | Neural / glial | 38 | 2 | 4 | 8 | |
| 3485 | Major depressive disorder | PSYCH000027 | 0.64 | Psychiatric | Neural / glial | 0 | 2 | 6 | 6 | |
| 3486 | HYOU1 levels | PROLV001002 | 0.64 | Protein levels | Hepatocyte | 168 | 1 | 4 | 14 | |
| 3487 | EIF4EBP1 levels | PROLV000697 | 0.64 | Protein levels | Muscle / cardiac | 5 | 3 | 9 | 20 | |
| 3488 | FABP4 levels | PROLV000754 | 0.64 | Protein levels | Stromal / connective | 8 | 0 | 3 | 6 | |
| 3489 | Cancer, Liver | MALIG000018 | 0.64 | Malignancy | Hepatocyte | 15 | 1 | 6 | 17 | |
| 3490 | LGALS4/TIE1 ratio | PRORT001451 | 0.64 | Protein ratios | Hepatocyte | 12 | 0 | 5 | 10 | |
| 3491 | SERPINA11 levels | PROLV001815 | 0.64 | Protein levels | Hepatocyte | 203 | 1 | 7 | 13 | |
| 3492 | CEBPB/PXN ratio | PRORT000592 | 0.64 | Protein ratios | Neural / glial | 0 | 3 | 6 | 17 | |
| 3493 | FXN/METAP1D ratio | PRORT001194 | 0.64 | Protein ratios | Neural / glial | 3 | 3 | 7 | 19 | |
| 3494 | IL6ST/TYRO3 ratio | PRORT001357 | 0.64 | Protein ratios | Neural / glial | 0 | 2 | 2 | 7 | |
| 3495 | PTS levels | PROLV001684 | 0.64 | Protein levels | Hepatocyte | 20 | 1 | 8 | 19 | |
| 3496 | CX3CL1/PODXL2 ratio | PRORT000810 | 0.64 | Protein ratios | Vascular | 14 | 3 | 10 | 15 | |
| 3497 | NFATC3 levels | PROLV001396 | 0.64 | Protein levels | B / plasma cell | 57 | 3 | 10 | 17 | |
| 3498 | MANSC1/PODXL ratio | PRORT001483 | 0.64 | Protein ratios | Hepatocyte | 5 | 1 | 8 | 13 | |
| 3499 | Intrahepatic cholestasis of pregnancy, ICP | HPBIL000001 | 0.63 | Hepatopancreatobiliary | Hepatocyte | 97 | 1 | 6 | 8 | |
| 3500 | GYS1/PPP1R2 ratio | PRORT001255 | 0.63 | Protein ratios | Melanocyte | 0 | 1 | 5 | 12 | |
| 3501 | FAM13A levels | PROLV000759 | 0.63 | Protein levels | Neural / glial | 16 | 4 | 8 | 22 | |
| 3502 | TXLNA levels | PROLV002122 | 0.63 | Protein levels | Platelet | 3 | 1 | 5 | 17 | |
| 3503 | Nasal septum deviation | RESPI000038 | 0.63 | Respiratory | Epithelial | 1 | 2 | 14 | 15 | |
| 3504 | PGLYRP2 levels | PROLV001547 | 0.63 | Protein levels | Hepatocyte | 58 | 1 | 4 | 8 | |
| 3505 | SIRT2/STAT5B ratio | PRORT001787 | 0.63 | Protein ratios | Hepatocyte | 8 | 2 | 7 | 17 | |
| 3506 | ICAM3/LY9 ratio | PRORT001326 | 0.63 | Protein ratios | B / plasma cell | 36 | 3 | 13 | 42 | |
| 3507 | ACY1/DCXR ratio | PRORT000019 | 0.63 | Protein ratios | Hepatocyte | 6 | 2 | 10 | 15 | |
| 3508 | Functional gastrointestinal disorder | GASTR000003 | 0.62 | Gastrointestinal | Neural / glial | 0 | 1 | 6 | 18 | |
| 3509 | Vitamin D | METAB000078 | 0.62 | Metabolites | Hepatocyte | 336 | 1 | 5 | 8 | |
| 3510 | Spleen volume | HEMAT000042 | 0.62 | Hematologic | B / plasma cell | 17 | 4 | 8 | 13 | |
| 3511 | Cardiac procedure, angioplasty | VASCU000057 | 0.62 | Vascular | Vascular | 102 | 4 | 10 | 20 | |
| 3512 | Coagulation disorder | HEMAT000017 | 0.62 | Hematologic | Stromal / connective | 25 | 1 | 3 | 10 | |
| 3513 | Hypothyroidism | ENDOC000021 | 0.62 | Endocrine | Lymphocyte | 371 | 1 | 12 | 20 | |
| 3514 | FAS levels | PROLV000770 | 0.62 | Protein levels | Muscle / cardiac | 1 | 1 | 5 | 9 | |
| 3515 | SAMD9L levels | PROLV001774 | 0.62 | Protein levels | Lymphocyte | 1 | 3 | 7 | 17 | |
| 3516 | CD40LG/TRAF2 ratio | PRORT000455 | 0.62 | Protein ratios | Lymphocyte | 4 | 2 | 13 | 45 | |
| 3517 | TXNL1 levels | PROLV002126 | 0.62 | Protein levels | Lymphocyte | 35 | 2 | 13 | 14 | |
| 3518 | SCRN1 levels | PROLV001794 | 0.62 | Protein levels | Adipose | 0 | 3 | 6 | 17 | |
| 3519 | SIRT2 levels | PROLV001870 | 0.62 | Protein levels | Myeloid | 30 | 5 | 9 | 17 | |
| 3520 | LZTFL1 levels | PROLV001256 | 0.61 | Protein levels | Myeloid | 5 | 3 | 6 | 14 | |
| 3521 | Legume preference | DTSUP000014 | 0.61 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 18 | |
| 3522 | Orbital disorder | OPHTH000021 | 0.61 | Ophthalmic | Lymphocyte | 47 | 3 | 15 | 38 | |
| 3523 | Gut microbial abundance, Provencibacterium | GASTR000032 | 0.61 | Gastrointestinal | Cutaneous epithelium | 0 | 1 | 12 | 9 | |
| 3524 | KLK15 levels | PROLV001155 | 0.61 | Protein levels | Hepatocyte | 35 | 1 | 9 | 7 | |
| 3525 | Acne | DERMA000028 | 0.61 | Dermatologic | Cutaneous epithelium | 14 | 0 | 8 | 7 | |
| 3526 | SARG levels | PROLV001776 | 0.61 | Protein levels | Stromal / connective | 8 | 5 | 10 | 22 | |
| 3527 | Cortical thickness | NIMAG000010 | 0.61 | Neuroimaging | Neural / glial | 39 | 3 | 7 | 20 | |
| 3528 | HLA-DMA levels | PROLV000973 | 0.61 | Protein levels | Vascular | 4 | 0 | 2 | 1 | |
| 3529 | CD200R1 levels | PROLV000317 | 0.60 | Protein levels | Adipose | 54 | 2 | 5 | 14 | |
| 3530 | EPS8L2 levels | PROLV000723 | 0.60 | Protein levels | Stromal / connective | 20 | 0 | 10 | 20 | |
| 3531 | SCAMP3/STX4 ratio | PRORT001756 | 0.60 | Protein ratios | Vascular | 3 | 2 | 8 | 11 | |
| 3532 | EPCAM/GPA33 ratio | PRORT001035 | 0.60 | Protein ratios | B / plasma cell | 22 | 0 | 5 | 4 | |
| 3533 | CRELD2/ERP44 ratio | PRORT000754 | 0.60 | Protein ratios | Salivary epithelium | 70 | 1 | 10 | 16 | |
| 3534 | TNFRSF17 levels | PROLV002066 | 0.60 | Protein levels | B / plasma cell | 116 | 3 | 15 | 18 | |
| 3535 | MANSC1 levels | PROLV001263 | 0.60 | Protein levels | Hepatocyte | 146 | 1 | 7 | 12 | |
| 3536 | P4HB levels | PROLV001481 | 0.60 | Protein levels | Stromal / connective | 66 | 2 | 7 | 26 | |
| 3537 | MED18/TACC3 ratio | PRORT001510 | 0.60 | Protein ratios | Lymphocyte | 0 | 4 | 8 | 24 | |
| 3538 | GP6/SELP ratio | PRORT001235 | 0.60 | Protein ratios | Myeloid | 0 | 3 | 6 | 14 | |
| 3539 | GLOD4 levels | PROLV000896 | 0.59 | Protein levels | Vascular | 2 | 4 | 10 | 31 | |
| 3540 | CGREF1 levels | PROLV000421 | 0.59 | Protein levels | Hepatocyte | 11 | 0 | 6 | 9 | |
| 3541 | FGD3 levels | PROLV000792 | 0.59 | Protein levels | Platelet | 25 | 4 | 8 | 18 | |
| 3542 | HNRNPUL1 levels | PROLV000983 | 0.59 | Protein levels | Lymphocyte | 15 | 4 | 11 | 41 | |
| 3543 | Family history, lung cancer | MALIG000039 | 0.59 | Malignancy | Lymphocyte | 7 | 2 | 7 | 21 | |
| 3544 | HSD11B1/SMPD1 ratio | PRORT001302 | 0.59 | Protein ratios | Hepatocyte | 78 | 1 | 6 | 17 | |
| 3545 | Bursitis | MSKEL000059 | 0.59 | Musculoskeletal | Hematopoietic progenitor | 0 | 1 | 3 | 7 | |
| 3546 | RET levels | PROLV001724 | 0.59 | Protein levels | Stromal / connective | 18 | 5 | 10 | 21 | |
| 3547 | EBV EA-D antibody | IMMUN000060 | 0.59 | Immunologic | Muscle / cardiac | 8 | 1 | 5 | 13 | |
| 3548 | Smoking dependency | PSYCH000047 | 0.59 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 3549 | NTN4 levels | PROLV001445 | 0.59 | Protein levels | Myeloid | 0 | 1 | 4 | 10 | |
| 3550 | Tryptophan metabolites | METAB000015 | 0.59 | Metabolites | Hepatocyte | 39 | 0 | 2 | 11 | |
| 3551 | Ocular motility and refraction disorder | OPHTH000024 | 0.59 | Ophthalmic | Adipose | 7 | 3 | 5 | 12 | |
| 3552 | Hypertensive disorders of pregnancy | VASCU000046 | 0.58 | Vascular | Vascular | 7 | 4 | 9 | 20 | |
| 3553 | EPO levels | PROLV000721 | 0.58 | Protein levels | Muscle / cardiac | 23 | 2 | 7 | 18 | |
| 3554 | Cardiomyopathy | CARDI000040 | 0.58 | Cardiac | Muscle / cardiac | 51 | 2 | 3 | 3 | |
| 3555 | DSG3/DSG4 ratio | PRORT000952 | 0.58 | Protein ratios | Cutaneous epithelium | 11 | 1 | 6 | 11 | |
| 3556 | CHMP6 levels | PROLV000432 | 0.58 | Protein levels | Stromal / connective | 7 | 4 | 6 | 19 | |
| 3557 | Copper | METAB000045 | 0.58 | Metabolites | Muscle / cardiac | 0 | 3 | 6 | 21 | |
| 3558 | Body mass index, BMI | BMORP000002 | 0.58 | Body morphology | Neural / glial | 1,808 | 5 | 9 | 17 | |
| 3559 | OGA levels | PROLV001463 | 0.58 | Protein levels | Lymphocyte | 7 | 5 | 11 | 29 | |
| 3560 | IFNGR1 levels | PROLV001020 | 0.58 | Protein levels | Myeloid | 139 | 1 | 7 | 10 | |
| 3561 | GLRX5 levels | PROLV000898 | 0.58 | Protein levels | Stromal / connective | 3 | 3 | 6 | 16 | |
| 3562 | Tyrosine metabolites | METAB000016 | 0.58 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 3563 | CCL22/TIMP3 ratio | PRORT000352 | 0.58 | Protein ratios | Vascular | 5 | 2 | 7 | 19 | |
| 3564 | Dietary restriction | DTSUP000009 | 0.58 | Diet and Supplement | Neural / glial | 67 | 4 | 10 | 35 | |
| 3565 | THTPA levels | PROLV002030 | 0.58 | Protein levels | Neural / glial | 0 | 4 | 9 | 37 | |
| 3566 | TGFBI/VASN ratio | PRORT001832 | 0.58 | Protein ratios | Hepatocyte | 27 | 2 | 5 | 4 | |
| 3567 | MGLL levels | PROLV001309 | 0.57 | Protein levels | Platelet | 25 | 2 | 5 | 9 | |
| 3568 | ADGRG1 levels | PROLV000046 | 0.57 | Protein levels | Vascular | 22 | 3 | 11 | 26 | |
| 3569 | COL6A3/SPON2 ratio | PRORT000701 | 0.57 | Protein ratios | Neural / glial | 20 | 3 | 6 | 25 | |
| 3570 | Brain ventricle volume | NIMAG000016 | 0.57 | Neuroimaging | Stromal / connective | 27 | 1 | 2 | 13 | |
| 3571 | GP6 levels | PROLV000917 | 0.57 | Protein levels | Myeloid | 21 | 2 | 6 | 18 | |
| 3572 | Menstrual disorder | REPRO000021 | 0.57 | Reproductive | Vascular | 6 | 0 | 2 | 3 | |
| 3573 | HEXIM1 levels | PROLV000964 | 0.57 | Protein levels | Myeloid | 2 | 3 | 7 | 23 | |
| 3574 | GNE levels | PROLV000904 | 0.57 | Protein levels | Myeloid | 3 | 2 | 4 | 11 | |
| 3575 | GKN1 levels | PROLV000891 | 0.57 | Protein levels | Vascular | 10 | 0 | 10 | 19 | |
| 3576 | PTPRS levels | PROLV001681 | 0.56 | Protein levels | Lymphocyte | 21 | 2 | 9 | 37 | |
| 3577 | Phosphatidylglycerols | LIPID000060 | 0.56 | Lipids | Granulosa cell | 3 | 3 | 10 | 22 | |
| 3578 | AGT levels | PROLV000059 | 0.56 | Protein levels | Hepatocyte | 53 | 2 | 5 | 10 | |
| 3579 | CST6/NECTIN4 ratio | PRORT000792 | 0.56 | Protein ratios | Epithelial | 3 | 1 | 5 | 13 | |
| 3580 | Hereditary haemolytic anaemia | HEMAT000010 | 0.56 | Hematologic | B / plasma cell | 0 | 1 | 7 | 5 | |
| 3581 | BLMH/PEAR1 ratio | PRORT000236 | 0.56 | Protein ratios | Hepatocyte | 17 | 3 | 13 | 15 | |
| 3582 | NUB1/SRPK2 ratio | PRORT001605 | 0.56 | Protein ratios | Myeloid | 0 | 1 | 5 | 8 | |
| 3583 | TALDO1 levels | PROLV001991 | 0.56 | Protein levels | Lymphocyte | 8 | 3 | 10 | 40 | |
| 3584 | IGSF8/VSIR ratio | PRORT001340 | 0.56 | Protein ratios | Myeloid | 12 | 3 | 8 | 15 | |
| 3585 | Amino acid metabolites | METAB000002 | 0.56 | Metabolites | Neural / glial | 0 | 0 | 7 | 11 | |
| 3586 | PDGFA/SPARC ratio | PRORT001637 | 0.56 | Protein ratios | Hematopoietic progenitor | 6 | 3 | 6 | 15 | |
| 3587 | Sedentary behaviour | BEHAV000008 | 0.56 | Behavioural | Neural / glial | 111 | 4 | 9 | 20 | |
| 3588 | LEP levels | PROLV001199 | 0.56 | Protein levels | Neural / glial | 1 | 0 | 8 | 12 | |
| 3589 | KIAA0040 levels | PROLV001136 | 0.56 | Protein levels | Stromal / connective | 0 | 2 | 8 | 14 | |
| 3590 | ESAM/TNFRSF14 ratio | PRORT001069 | 0.56 | Protein ratios | Vascular | 1 | 3 | 12 | 27 | |
| 3591 | CMC1 levels | PROLV000469 | 0.55 | Protein levels | Stromal / connective | 28 | 2 | 5 | 14 | |
| 3592 | CPXM1/LGMN ratio | PRORT000734 | 0.55 | Protein ratios | Platelet | 10 | 3 | 6 | 11 | |
| 3593 | SRPK2/VASH1 ratio | PRORT001815 | 0.55 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 25 | |
| 3594 | Dissociative disorder | PSYCH000012 | 0.55 | Psychiatric | Lymphocyte | 0 | 2 | 14 | 19 | |
| 3595 | CNTN5 levels | PROLV000479 | 0.55 | Protein levels | Myeloid | 1 | 4 | 6 | 13 | |
| 3596 | EVI5 levels | PROLV000737 | 0.55 | Protein levels | Myeloid | 1 | 2 | 8 | 16 | |
| 3597 | LGALS4/PCDH17 ratio | PRORT001450 | 0.55 | Protein ratios | B / plasma cell | 4 | 2 | 6 | 10 | |
| 3598 | Pregnancy complication, abortive | REPRO000027 | 0.55 | Reproductive | Neural / glial | 0 | 5 | 7 | 18 | |
| 3599 | GIT1 levels | PROLV000890 | 0.54 | Protein levels | Stromal / connective | 7 | 2 | 3 | 9 | |
| 3600 | GUCA2A/LGALS4 ratio | PRORT001254 | 0.54 | Protein ratios | Epithelial | 17 | 0 | 7 | 7 | |
| 3601 | PTPRF/PTPRS ratio | PRORT001721 | 0.54 | Protein ratios | Hepatocyte | 76 | 4 | 11 | 24 | |
| 3602 | ASGR1/GGT5 ratio | PRORT000148 | 0.54 | Protein ratios | Hepatocyte | 60 | 1 | 9 | 18 | |
| 3603 | GZMA/GZMH ratio | PRORT001258 | 0.54 | Protein ratios | Lymphocyte | 23 | 2 | 12 | 23 | |
| 3604 | SIRT1 levels | PROLV001869 | 0.54 | Protein levels | Muscle / cardiac | 6 | 2 | 11 | 20 | |
| 3605 | Gestational hypertension | VASCU000045 | 0.54 | Vascular | Lymphocyte | 3 | 1 | 7 | 22 | |
| 3606 | PPP2R5A levels | PROLV001619 | 0.54 | Protein levels | Vascular | 7 | 2 | 4 | 12 | |
| 3607 | Severe mental illness | PSYCH000017 | 0.54 | Psychiatric | Neural / glial | 0 | 4 | 8 | 10 | |
| 3608 | NOTCH1 levels | PROLV001416 | 0.54 | Protein levels | Hepatocyte | 100 | 2 | 7 | 17 | |
| 3609 | Facial ageing | DERMA000039 | 0.54 | Dermatologic | Melanocyte | 22 | 0 | 0 | 0 | |
| 3610 | AXIN1/SRPK2 ratio | PRORT000177 | 0.53 | Protein ratios | Hepatocyte | 0 | 3 | 12 | 38 | |
| 3611 | MVK levels | PROLV001354 | 0.53 | Protein levels | Stromal / connective | 0 | 5 | 9 | 38 | |
| 3612 | Supplement use, dietary | DTSUP000024 | 0.53 | Diet and Supplement | Neural / glial | 7 | 5 | 10 | 20 | |
| 3613 | CD2AP levels | PROLV000328 | 0.53 | Protein levels | Vascular | 8 | 3 | 8 | 33 | |
| 3614 | Glycine | METAB000022 | 0.53 | Metabolites | Hepatocyte | 498 | 1 | 7 | 11 | |
| 3615 | DEFB4A or DEFB4B levels | PROLV000614 | 0.53 | Protein levels | Hepatocyte | 48 | 1 | 7 | 15 | |
| 3616 | Thyroid stimulating hormone, TSH | ENDOC000017 | 0.53 | Endocrine | Epithelial | 326 | 1 | 10 | 7 | |
| 3617 | TBCB levels | PROLV001999 | 0.53 | Protein levels | Platelet | 7 | 6 | 10 | 17 | |
| 3618 | Spread preference | DTSUP000018 | 0.53 | Diet and Supplement | Neural / glial | 14 | 2 | 6 | 13 | |
| 3619 | FSTL3 levels | PROLV000831 | 0.53 | Protein levels | Neural / glial | 17 | 2 | 3 | 8 | |
| 3620 | Intracerebral haemorrhage | VASCU000014 | 0.53 | Vascular | Stromal / connective | 0 | 6 | 14 | 20 | |
| 3621 | XIAP levels | PROLV002198 | 0.53 | Protein levels | Stromal / connective | 2 | 3 | 5 | 18 | |
| 3622 | FABP1/RBP2 ratio | PRORT001096 | 0.53 | Protein ratios | Hepatocyte | 29 | 1 | 7 | 8 | |
| 3623 | CNPY4/MESD ratio | PRORT000680 | 0.53 | Protein ratios | Hepatocyte | 4 | 5 | 10 | 27 | |
| 3624 | CKAP4 levels | PROLV000439 | 0.53 | Protein levels | Hepatocyte | 101 | 3 | 10 | 21 | |
| 3625 | Soft tissue disorder | MSKEL000069 | 0.53 | Musculoskeletal | Neural / glial | 21 | 2 | 7 | 6 | |
| 3626 | PLA2G4A levels | PROLV001569 | 0.53 | Protein levels | Platelet | 5 | 3 | 5 | 14 | |
| 3627 | SDC1 levels | PROLV001796 | 0.52 | Protein levels | Hepatocyte | 98 | 1 | 9 | 9 | |
| 3628 | MAVS/ZBTB16 ratio | PRORT001502 | 0.52 | Protein ratios | Muscle / cardiac | 10 | 4 | 5 | 11 | |
| 3629 | CXCL10/WARS ratio | PRORT000815 | 0.52 | Protein ratios | Hepatocyte | 4 | 2 | 9 | 17 | |
| 3630 | CNP levels | PROLV000472 | 0.52 | Protein levels | Stromal / connective | 1 | 3 | 9 | 29 | |
| 3631 | ENG/NCAM2 ratio | PRORT001017 | 0.52 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 6 | 15 | |
| 3632 | FTCD levels | PROLV000832 | 0.52 | Protein levels | Hepatocyte | 62 | 1 | 8 | 22 | |
| 3633 | PMM2 levels | PROLV001589 | 0.52 | Protein levels | Stromal / connective | 2 | 2 | 6 | 12 | |
| 3634 | COL6A3/TAFA5 ratio | PRORT000702 | 0.52 | Protein ratios | Hepatocyte | 31 | 5 | 7 | 24 | |
| 3635 | Gut microbial abundance, Alistipes | GASTR000018 | 0.52 | Gastrointestinal | Neural / glial | 0 | 6 | 11 | 30 | |
| 3636 | CLEC1B/LBR ratio | PRORT000641 | 0.52 | Protein ratios | Hepatocyte | 1 | 2 | 6 | 15 | |
| 3637 | BCR levels | PROLV000190 | 0.52 | Protein levels | Vascular | 29 | 3 | 7 | 17 | |
| 3638 | Endometriosis | REPRO000005 | 0.51 | Reproductive | Stromal / connective | 49 | 1 | 4 | 8 | |
| 3639 | MED18 levels | PROLV001292 | 0.51 | Protein levels | Myeloid | 23 | 5 | 10 | 12 | |
| 3640 | Creatine metabolites | METAB000058 | 0.51 | Metabolites | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 3641 | TNFRSF14 levels | PROLV002065 | 0.51 | Protein levels | Lymphocyte | 13 | 3 | 6 | 17 | |
| 3642 | Chronic obstructive pulmonary disease, COPD | RESPI000009 | 0.51 | Respiratory | Neural / glial | 75 | 1 | 2 | 6 | |
| 3643 | VWF levels | PROLV002182 | 0.51 | Protein levels | Vascular | 12 | 2 | 5 | 13 | |
| 3644 | VPS37A levels | PROLV002166 | 0.51 | Protein levels | Hepatocyte | 40 | 2 | 6 | 17 | |
| 3645 | Peripheral artery disease | VASCU000042 | 0.51 | Vascular | Vascular | 44 | 3 | 9 | 23 | |
| 3646 | CD200 levels | PROLV000316 | 0.51 | Protein levels | Adipose | 41 | 1 | 7 | 7 | |
| 3647 | AZU1 levels | PROLV000168 | 0.51 | Protein levels | Muscle / cardiac | 18 | 3 | 4 | 8 | |
| 3648 | CDC27 levels | PROLV000367 | 0.51 | Protein levels | Lymphocyte | 4 | 3 | 9 | 24 | |
| 3649 | DDR1/PVR ratio | PRORT000879 | 0.51 | Protein ratios | Hepatocyte | 15 | 1 | 7 | 13 | |
| 3650 | JAM2/RGMB ratio | PRORT001396 | 0.51 | Protein ratios | Vascular | 2 | 2 | 6 | 11 | |
| 3651 | SRP14 levels | PROLV001943 | 0.51 | Protein levels | Lymphocyte | 4 | 2 | 14 | 26 | |
| 3652 | DNAJB2 levels | PROLV000632 | 0.51 | Protein levels | Lymphocyte | 19 | 4 | 17 | 45 | |
| 3653 | MATN3 levels | PROLV001278 | 0.51 | Protein levels | Hepatocyte | 62 | 2 | 6 | 6 | |
| 3654 | Peripheral vascular disease | VASCU000043 | 0.51 | Vascular | Stromal / connective | 65 | 3 | 6 | 14 | |
| 3655 | Mononeuropathy | NEURO000027 | 0.51 | Neurologic | Stromal / connective | 2 | 0 | 0 | 3 | |
| 3656 | Smoking behaviour | PSYCH000046 | 0.51 | Psychiatric | Neural / glial | 201 | 5 | 10 | 23 | |
| 3657 | ILKAP levels | PROLV001082 | 0.51 | Protein levels | Vascular | 6 | 0 | 3 | 17 | |
| 3658 | KCNA10 levels | PROLV001130 | 0.51 | Protein levels | Stromal / connective | 0 | 1 | 1 | 8 | |
| 3659 | MAVS levels | PROLV001279 | 0.50 | Protein levels | Myeloid | 7 | 3 | 3 | 11 | |
| 3660 | Family history, dyslipidaemia | METBL000010 | 0.50 | Metabolic | Hepatocyte | 64 | 1 | 6 | 10 | |
| 3661 | Bundle branch block | CARDI000029 | 0.50 | Cardiac | Muscle / cardiac | 13 | 3 | 6 | 11 | |
| 3662 | NIT2 levels | PROLV001408 | 0.50 | Protein levels | Stromal / connective | 2 | 4 | 8 | 14 | |
| 3663 | PLA2G1B/PRSS2 ratio | PRORT001672 | 0.50 | Protein ratios | Hepatocyte | 44 | 1 | 2 | 8 | |
| 3664 | SERPINH1 levels | PROLV001835 | 0.50 | Protein levels | Vascular | 20 | 1 | 7 | 16 | |
| 3665 | RND3 levels | PROLV001743 | 0.50 | Protein levels | Hepatocyte | 16 | 2 | 10 | 23 | |
| 3666 | NCR1 levels | PROLV001382 | 0.50 | Protein levels | Lymphocyte | 117 | 2 | 14 | 32 | |
| 3667 | Venous thromboembolism, VTE | VASCU000066 | 0.50 | Vascular | Hepatocyte | 189 | 1 | 5 | 11 | |
| 3668 | CDSN/NECTIN4 ratio | PRORT000584 | 0.50 | Protein ratios | Cutaneous epithelium | 16 | 1 | 7 | 12 | |
| 3669 | Heart failure, chronic | CARDI000003 | 0.50 | Cardiac | Muscle / cardiac | 0 | 3 | 7 | 16 | |
| 3670 | Hypothyroidism, subclinical in pregnancy | ENDOC000016 | 0.50 | Endocrine | Hematopoietic progenitor | 0 | 1 | 4 | 8 | |
| 3671 | KIFBP levels | PROLV001140 | 0.50 | Protein levels | Myeloid | 33 | 1 | 5 | 9 | |
| 3672 | Gut microbial abundance, Rikenellaceae | GASTR000034 | 0.50 | Gastrointestinal | Neural / glial | 0 | 6 | 10 | 28 | |
| 3673 | MED18/SMAD1 ratio | PRORT001509 | 0.50 | Protein ratios | Hepatocyte | 2 | 4 | 15 | 37 | |
| 3674 | IKBKG levels | PROLV001041 | 0.50 | Protein levels | Hepatocyte | 7 | 1 | 5 | 13 | |
| 3675 | FHIT/GLOD4 ratio | PRORT001144 | 0.50 | Protein ratios | Lymphocyte | 0 | 1 | 6 | 29 | |
| 3676 | Ischaemic heart disease | CARDI000041 | 0.50 | Cardiac | Vascular | 595 | 3 | 10 | 19 | |
| 3677 | SCAMP3/VPS53 ratio | PRORT001757 | 0.49 | Protein ratios | Vascular | 0 | 2 | 9 | 19 | |
| 3678 | ROBO2 levels | PROLV001750 | 0.49 | Protein levels | Adipose | 69 | 5 | 10 | 24 | |
| 3679 | EGF levels | PROLV000684 | 0.49 | Protein levels | Myeloid | 47 | 2 | 7 | 21 | |
| 3680 | EGF/PPIB ratio | PRORT000998 | 0.49 | Protein ratios | Myeloid | 9 | 2 | 7 | 15 | |
| 3681 | Hearing loss, age-related | AUDIO000006 | 0.49 | Auditory | Neural / glial | 4 | 3 | 13 | 14 | |
| 3682 | HTRA2 levels | PROLV001000 | 0.49 | Protein levels | Stromal / connective | 9 | 3 | 7 | 14 | |
| 3683 | ICAM2/IL7R ratio | PRORT001324 | 0.49 | Protein ratios | Vascular | 6 | 1 | 8 | 17 | |
| 3684 | PRSS8 levels | PROLV001648 | 0.49 | Protein levels | Epithelial | 26 | 1 | 5 | 8 | |
| 3685 | CLPS levels | PROLV000463 | 0.49 | Protein levels | Vascular | 68 | 1 | 3 | 10 | |
| 3686 | Stressful life events | PSYCH000053 | 0.49 | Psychiatric | Neural / glial | 0 | 5 | 9 | 21 | |
| 3687 | STAMBP/WWP2 ratio | PRORT001817 | 0.48 | Protein ratios | Muscle / cardiac | 8 | 4 | 9 | 20 | |
| 3688 | CLIP2/NT5C3A ratio | PRORT000667 | 0.48 | Protein ratios | Muscle / cardiac | 0 | 4 | 5 | 13 | |
| 3689 | ESAM/SORT1 ratio | PRORT001066 | 0.48 | Protein ratios | Vascular | 14 | 2 | 8 | 14 | |
| 3690 | DCTN6/TDRKH ratio | PRORT000875 | 0.48 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 31 | |
| 3691 | Family medical history, none | MISCL000010 | 0.48 | Miscellaneous | Vascular | 6 | 0 | 0 | 3 | |
| 3692 | NECTIN2/SPON2 ratio | PRORT001579 | 0.48 | Protein ratios | Hepatocyte | 17 | 1 | 5 | 10 | |
| 3693 | CRYBB1 levels | PROLV000532 | 0.48 | Protein levels | Lymphocyte | 15 | 5 | 12 | 33 | |
| 3694 | TSPAN8 levels | PROLV002116 | 0.48 | Protein levels | Hepatocyte | 56 | 1 | 9 | 15 | |
| 3695 | FCRL2 levels | PROLV000784 | 0.48 | Protein levels | B / plasma cell | 91 | 1 | 4 | 7 | |
| 3696 | PDCD6 levels | PROLV001518 | 0.48 | Protein levels | Muscle / cardiac | 54 | 3 | 13 | 24 | |
| 3697 | Loose teeth | DENTA000012 | 0.48 | Dental | Neural / glial | 1 | 2 | 7 | 12 | |
| 3698 | Mammary dysplasia | BREAS000001 | 0.48 | Breast | Adipose | 0 | 1 | 8 | 17 | |
| 3699 | YARS1 levels | PROLV002203 | 0.48 | Protein levels | Stromal / connective | 1 | 4 | 7 | 20 | |
| 3700 | Tyrosine | METAB000031 | 0.48 | Metabolites | Hepatocyte | 258 | 1 | 5 | 10 | |
| 3701 | F3 levels | PROLV000746 | 0.48 | Protein levels | Vascular | 50 | 0 | 8 | 7 | |
| 3702 | EGF/GP6 ratio | PRORT000994 | 0.48 | Protein ratios | Myeloid | 9 | 2 | 6 | 10 | |
| 3703 | STC1 levels | PROLV001960 | 0.48 | Protein levels | Vascular | 2 | 1 | 6 | 12 | |
| 3704 | Diabetes, gestational | METBL000031 | 0.48 | Metabolic | Hepatocyte | 48 | 1 | 5 | 5 | |
| 3705 | Family history, coronary artery disease | VASCU000021 | 0.47 | Vascular | Vascular | 26 | 0 | 2 | 7 | |
| 3706 | SKAP1 levels | PROLV001872 | 0.47 | Protein levels | Lymphocyte | 90 | 2 | 11 | 18 | |
| 3707 | EFNA4/LAYN ratio | PRORT000990 | 0.47 | Protein ratios | Muscle / cardiac | 3 | 3 | 8 | 13 | |
| 3708 | MMP13 levels | PROLV001324 | 0.47 | Protein levels | Stromal / connective | 0 | 1 | 4 | 5 | |
| 3709 | Plasma protein metabolism disorder | METBL000029 | 0.47 | Metabolic | Hepatocyte | 26 | 2 | 6 | 24 | |
| 3710 | BCL2L11 levels | PROLV000187 | 0.47 | Protein levels | Myeloid | 90 | 2 | 7 | 17 | |
| 3711 | Waist-hip ratio | BMORP000014 | 0.47 | Body morphology | Adipose | 523 | 3 | 5 | 10 | |
| 3712 | GPC1 levels | PROLV000919 | 0.47 | Protein levels | Muscle / cardiac | 104 | 2 | 6 | 8 | |
| 3713 | ADAMTS15/SULT2A1 ratio | PRORT000025 | 0.47 | Protein ratios | Hepatocyte | 59 | 1 | 6 | 9 | |
| 3714 | Medication, antiglaucoma | OPHTH000014 | 0.47 | Ophthalmic | Stromal / connective | 69 | 2 | 5 | 12 | |
| 3715 | Carotid plaque | VASCU000054 | 0.47 | Vascular | Vascular | 2 | 1 | 4 | 9 | |
| 3716 | PDAP1 levels | PROLV001514 | 0.47 | Protein levels | Stromal / connective | 4 | 3 | 6 | 16 | |
| 3717 | SDC4/SEMA4D ratio | PRORT001766 | 0.47 | Protein ratios | Myeloid | 22 | 2 | 5 | 13 | |
| 3718 | CDH5/TEK ratio | PRORT000561 | 0.47 | Protein ratios | Vascular | 42 | 2 | 8 | 11 | |
| 3719 | Uterine or vaginal bleeding | REPRO000044 | 0.47 | Reproductive | Stromal / connective | 0 | 5 | 8 | 16 | |
| 3720 | Medication, anti-obesity | METBL000026 | 0.46 | Metabolic | Neural / glial | 0 | 1 | 4 | 11 | |
| 3721 | AXIN1 levels | PROLV000166 | 0.46 | Protein levels | Lymphocyte | 21 | 3 | 7 | 26 | |
| 3722 | CD27/CD79B ratio | PRORT000411 | 0.46 | Protein ratios | B / plasma cell | 12 | 3 | 15 | 22 | |
| 3723 | S100A16 levels | PROLV001770 | 0.46 | Protein levels | Vascular | 10 | 0 | 4 | 9 | |
| 3724 | MCAM/NTRK3 ratio | PRORT001506 | 0.46 | Protein ratios | Vascular | 17 | 2 | 8 | 14 | |
| 3725 | AGRN levels | PROLV000057 | 0.46 | Protein levels | Stromal / connective | 53 | 0 | 2 | 8 | |
| 3726 | IRAG2 levels | PROLV001096 | 0.46 | Protein levels | Vascular | 1 | 1 | 4 | 7 | |
| 3727 | Diabetes, type 1 | IMMUN000012 | 0.46 | Immunologic | Lymphocyte | 291 | 2 | 14 | 6 | |
| 3728 | GCC1 levels | PROLV000865 | 0.46 | Protein levels | Myeloid | 28 | 2 | 4 | 11 | |
| 3729 | KLK8/WFDC12 ratio | PRORT001413 | 0.46 | Protein ratios | Cutaneous epithelium | 7 | 1 | 13 | 21 | |
| 3730 | EBAG9 levels | PROLV000668 | 0.46 | Protein levels | Lymphocyte | 1 | 3 | 8 | 30 | |
| 3731 | CD27/TNFRSF13B ratio | PRORT000418 | 0.46 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 23 | |
| 3732 | DTYMK levels | PROLV000661 | 0.45 | Protein levels | Lymphocyte | 6 | 3 | 9 | 30 | |
| 3733 | Nasal polyp | RESPI000037 | 0.45 | Respiratory | Lymphocyte | 11 | 2 | 11 | 20 | |
| 3734 | SNAP25 levels | PROLV001906 | 0.45 | Protein levels | Muscle / cardiac | 18 | 1 | 5 | 11 | |
| 3735 | Hernia | GASTR000008 | 0.45 | Gastrointestinal | Stromal / connective | 183 | 2 | 4 | 8 | |
| 3736 | AXIN1/CDKN1A ratio | PRORT000166 | 0.45 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 3737 | UFD1 levels | PROLV002137 | 0.45 | Protein levels | Stromal / connective | 3 | 1 | 4 | 10 | |
| 3738 | ELN levels | PROLV000700 | 0.45 | Protein levels | Hepatocyte | 52 | 3 | 6 | 7 | |
| 3739 | PAFAH1B3 levels | PROLV001486 | 0.45 | Protein levels | Lymphocyte | 45 | 2 | 17 | 18 | |
| 3740 | PPP1R9B levels | PROLV001617 | 0.45 | Protein levels | Vascular | 18 | 2 | 5 | 15 | |
| 3741 | SERPINA6 levels | PROLV001820 | 0.45 | Protein levels | Hepatocyte | 34 | 2 | 10 | 13 | |
| 3742 | DLK1/PIK3IP1 ratio | PRORT000912 | 0.45 | Protein ratios | Stromal / connective | 1 | 4 | 10 | 35 | |
| 3743 | CETN2/PRTFDC1 ratio | PRORT000607 | 0.45 | Protein ratios | Neural / glial | 0 | 4 | 9 | 15 | |
| 3744 | NHLRC3 levels | PROLV001403 | 0.44 | Protein levels | Stromal / connective | 23 | 5 | 9 | 27 | |
| 3745 | Ventricular volume | CARDI000015 | 0.44 | Cardiac | Muscle / cardiac | 83 | 2 | 7 | 15 | |
| 3746 | Spondylopathy | MSKEL000080 | 0.44 | Musculoskeletal | Stromal / connective | 21 | 2 | 2 | 10 | |
| 3747 | PRKAR1A levels | PROLV001631 | 0.44 | Protein levels | Platelet | 0 | 5 | 11 | 23 | |
| 3748 | PLXNB3 levels | PROLV001587 | 0.44 | Protein levels | Muscle / cardiac | 12 | 2 | 6 | 13 | |
| 3749 | CD27/NBL1 ratio | PRORT000415 | 0.44 | Protein ratios | B / plasma cell | 23 | 3 | 12 | 25 | |
| 3750 | MAP4K5 levels | PROLV001269 | 0.44 | Protein levels | Stromal / connective | 21 | 3 | 9 | 10 | |
| 3751 | CAMSAP1 levels | PROLV000260 | 0.44 | Protein levels | Myeloid | 2 | 2 | 2 | 10 | |
| 3752 | ATG16L1 levels | PROLV000158 | 0.44 | Protein levels | Stromal / connective | 26 | 1 | 4 | 9 | |
| 3753 | DNMBP levels | PROLV000640 | 0.44 | Protein levels | Vascular | 2 | 1 | 3 | 9 | |
| 3754 | CRKL levels | PROLV000526 | 0.44 | Protein levels | Platelet | 7 | 5 | 8 | 18 | |
| 3755 | Urinary albumin | NEPHR000020 | 0.44 | Nephrourologic | Vascular | 29 | 2 | 10 | 12 | |
| 3756 | Cancer, Kidney | MALIG000016 | 0.44 | Malignancy | Pancreatic epithelium | 1 | 0 | 6 | 12 | |
| 3757 | MZB1 levels | PROLV001366 | 0.44 | Protein levels | Lymphocyte | 62 | 2 | 12 | 17 | |
| 3758 | CRTAM/TNFRSF9 ratio | PRORT000774 | 0.44 | Protein ratios | Lymphocyte | 7 | 3 | 17 | 30 | |
| 3759 | TNFSF11 levels | PROLV002076 | 0.44 | Protein levels | Hepatocyte | 28 | 3 | 10 | 14 | |
| 3760 | NUDC levels | PROLV001452 | 0.44 | Protein levels | Platelet | 3 | 3 | 3 | 10 | |
| 3761 | AGRN/CRIM1 ratio | PRORT000047 | 0.43 | Protein ratios | Adipose | 8 | 3 | 11 | 13 | |
| 3762 | AHCY levels | PROLV000061 | 0.43 | Protein levels | Vascular | 11 | 5 | 10 | 25 | |
| 3763 | Branched-chain amino acids | METAB000019 | 0.43 | Metabolites | Hepatocyte | 32 | 3 | 9 | 16 | |
| 3764 | CIAPIN1/SNAP29 ratio | PRORT000616 | 0.43 | Protein ratios | Hepatocyte | 2 | 2 | 7 | 21 | |
| 3765 | GMPR levels | PROLV000902 | 0.43 | Protein levels | Neural / glial | 10 | 4 | 7 | 18 | |
| 3766 | CAPS levels | PROLV000264 | 0.43 | Protein levels | Hematopoietic progenitor | 43 | 2 | 5 | 11 | |
| 3767 | BCAN/CD200 ratio | PRORT000214 | 0.43 | Protein ratios | Granulosa cell | 11 | 2 | 7 | 8 | |
| 3768 | Dihexosylceramides | LIPID000066 | 0.43 | Lipids | Neural / glial | 1 | 1 | 2 | 7 | |
| 3769 | F7/PROC ratio | PRORT001088 | 0.43 | Protein ratios | Hepatocyte | 35 | 1 | 10 | 12 | |
| 3770 | CRELD2 levels | PROLV000519 | 0.43 | Protein levels | Stromal / connective | 72 | 2 | 6 | 8 | |
| 3771 | KAZN levels | PROLV001129 | 0.43 | Protein levels | Stromal / connective | 3 | 2 | 6 | 26 | |
| 3772 | Hospital admission | MISCL000022 | 0.43 | Miscellaneous | Neural / glial | 1 | 3 | 6 | 25 | |
| 3773 | MAPK9 levels | PROLV001271 | 0.43 | Protein levels | Vascular | 0 | 3 | 8 | 17 | |
| 3774 | FUT8/RSPO1 ratio | PRORT001188 | 0.43 | Protein ratios | Lymphocyte | 9 | 2 | 11 | 28 | |
| 3775 | SNAP23/ZBTB16 ratio | PRORT001796 | 0.43 | Protein ratios | Lymphocyte | 9 | 3 | 8 | 23 | |
| 3776 | CD46/TIMP1 ratio | PRORT000461 | 0.43 | Protein ratios | Lymphocyte | 6 | 2 | 10 | 32 | |
| 3777 | DDHD2 levels | PROLV000609 | 0.43 | Protein levels | Vascular | 9 | 4 | 10 | 15 | |
| 3778 | Cancer, Brain | MALIG000010 | 0.43 | Malignancy | Muscle / cardiac | 0 | 2 | 4 | 13 | |
| 3779 | KDM3A levels | PROLV001132 | 0.43 | Protein levels | Lymphocyte | 21 | 2 | 16 | 40 | |
| 3780 | CWC15 levels | PROLV000572 | 0.42 | Protein levels | Lymphocyte | 7 | 2 | 12 | 34 | |
| 3781 | MAP4K5/TBCB ratio | PRORT001491 | 0.42 | Protein ratios | Neural / glial | 5 | 4 | 8 | 23 | |
| 3782 | NT5C3A/SCRN1 ratio | PRORT001603 | 0.42 | Protein ratios | Neural / glial | 12 | 5 | 6 | 20 | |
| 3783 | CEACAM21 levels | PROLV000391 | 0.42 | Protein levels | Hepatocyte | 22 | 2 | 15 | 22 | |
| 3784 | CDKN2D/FOXO1 ratio | PRORT000577 | 0.42 | Protein ratios | Lymphocyte | 0 | 2 | 9 | 25 | |
| 3785 | CD55 levels | PROLV000345 | 0.42 | Protein levels | Adipose | 54 | 0 | 9 | 16 | |
| 3786 | CASP10/PRTFDC1 ratio | PRORT000312 | 0.42 | Protein ratios | Hepatocyte | 6 | 2 | 7 | 15 | |
| 3787 | Phenylalanine metabolites | METAB000012 | 0.42 | Metabolites | Salivary epithelium | 4 | 0 | 4 | 6 | |
| 3788 | Arthropathy, enteropathic | IMMUN000009 | 0.42 | Immunologic | Lymphocyte | 10 | 0 | 3 | 15 | |
| 3789 | HARS1 levels | PROLV000952 | 0.42 | Protein levels | Platelet | 8 | 7 | 9 | 16 | |
| 3790 | CANT1/NUDT5 ratio | PRORT000308 | 0.42 | Protein ratios | Neural / glial | 0 | 2 | 3 | 18 | |
| 3791 | Benign neoplasm, Melanocytic | MALIG000004 | 0.42 | Malignancy | Stromal / connective | 2 | 0 | 0 | 5 | |
| 3792 | ART3/RGMA ratio | PRORT000145 | 0.42 | Protein ratios | Muscle / cardiac | 17 | 3 | 8 | 15 | |
| 3793 | CNDP1 levels | PROLV000471 | 0.42 | Protein levels | Hepatocyte | 75 | 2 | 12 | 12 | |
| 3794 | Rotator cuff injury | MSKEL000067 | 0.42 | Musculoskeletal | Stromal / connective | 0 | 3 | 7 | 17 | |
| 3795 | DNAJB6 levels | PROLV000633 | 0.41 | Protein levels | Platelet | 2 | 5 | 11 | 13 | |
| 3796 | Medication, antipyretic | MISCL000035 | 0.41 | Miscellaneous | Lymphocyte | 0 | 3 | 10 | 20 | |
| 3797 | CDSN/LY6D ratio | PRORT000583 | 0.41 | Protein ratios | Cutaneous epithelium | 33 | 2 | 18 | 32 | |
| 3798 | Weight | BMORP000015 | 0.41 | Body morphology | Neural / glial | 1,549 | 3 | 8 | 22 | |
| 3799 | FCAMR levels | PROLV000774 | 0.41 | Protein levels | Hepatocyte | 81 | 2 | 8 | 20 | |
| 3800 | TNFRSF1A levels | PROLV002068 | 0.41 | Protein levels | Stromal / connective | 42 | 0 | 7 | 7 | |
| 3801 | Subarachnoid haemorrhage | VASCU000018 | 0.41 | Vascular | Granulosa cell | 0 | 0 | 5 | 6 | |
| 3802 | PLCB2 levels | PROLV001575 | 0.41 | Protein levels | Platelet | 16 | 2 | 4 | 15 | |
| 3803 | Neonatal jaundice | HPBIL000004 | 0.41 | Hepatopancreatobiliary | Gastrointestinal epithelium | 2 | 2 | 7 | 13 | |
| 3804 | FXYD5 levels | PROLV000841 | 0.41 | Protein levels | Myeloid | 24 | 4 | 11 | 19 | |
| 3805 | IL4R levels | PROLV001075 | 0.41 | Protein levels | Hepatocyte | 92 | 2 | 11 | 15 | |
| 3806 | PODXL2/SCG3 ratio | PRORT001695 | 0.41 | Protein ratios | Hepatocyte | 28 | 1 | 7 | 13 | |
| 3807 | GMPR2 levels | PROLV000903 | 0.40 | Protein levels | Lymphocyte | 3 | 3 | 11 | 40 | |
| 3808 | ACYP1 levels | PROLV000021 | 0.40 | Protein levels | Lymphocyte | 14 | 2 | 12 | 34 | |
| 3809 | GP2/LGALS4 ratio | PRORT001229 | 0.40 | Protein ratios | Pancreatic epithelium | 36 | 0 | 3 | 4 | |
| 3810 | FGR levels | PROLV000804 | 0.40 | Protein levels | Adipose | 16 | 7 | 15 | 30 | |
| 3811 | PPIB levels | PROLV001606 | 0.40 | Protein levels | Vascular | 14 | 7 | 12 | 14 | |
| 3812 | Body fat percentage | BCOMP000004 | 0.40 | Body composition | Neural / glial | 409 | 3 | 9 | 19 | |
| 3813 | F11R/PARK7 ratio | PRORT001072 | 0.40 | Protein ratios | Hepatocyte | 0 | 1 | 7 | 26 | |
| 3814 | DAPP1 levels | PROLV000594 | 0.40 | Protein levels | Stromal / connective | 37 | 2 | 6 | 13 | |
| 3815 | Frailty, unhealthy lifestyle | BEHAV000002 | 0.40 | Behavioural | Myeloid | 5 | 5 | 9 | 16 | |
| 3816 | PDCD1LG2 levels | PROLV001516 | 0.40 | Protein levels | Hepatocyte | 48 | 1 | 7 | 10 | |
| 3817 | WASF1 levels | PROLV002185 | 0.40 | Protein levels | Myeloid | 2 | 1 | 1 | 7 | |
| 3818 | ATOX1/SNAP29 ratio | PRORT000151 | 0.40 | Protein ratios | Lymphocyte | 0 | 2 | 12 | 24 | |
| 3819 | ELOA/MAD1L1 ratio | PRORT001015 | 0.40 | Protein ratios | Myeloid | 4 | 3 | 9 | 15 | |
| 3820 | PSME1 levels | PROLV001658 | 0.40 | Protein levels | Stromal / connective | 0 | 3 | 9 | 18 | |
| 3821 | DNAJC6 levels | PROLV000635 | 0.40 | Protein levels | Hematopoietic progenitor | 9 | 5 | 7 | 15 | |
| 3822 | Respiratory symptom | RESPI000032 | 0.39 | Respiratory | Neural / glial | 10 | 4 | 12 | 19 | |
| 3823 | MOG/PTPRN2 ratio | PRORT001551 | 0.39 | Protein ratios | Neural / glial | 28 | 3 | 3 | 10 | |
| 3824 | Blood pressure, BP, pulse | VASCU000010 | 0.39 | Vascular | Stromal / connective | 1,008 | 5 | 7 | 16 | |
| 3825 | Coronary artery disease, CAD | VASCU000020 | 0.39 | Vascular | Vascular | 661 | 3 | 10 | 23 | |
| 3826 | Dentures | DENTA000006 | 0.39 | Dental | Neural / glial | 0 | 3 | 7 | 16 | |
| 3827 | TSTA3 levels | PROLV002118 | 0.39 | Protein levels | Vascular | 10 | 3 | 7 | 12 | |
| 3828 | CES1 levels | PROLV000405 | 0.39 | Protein levels | Hepatocyte | 148 | 1 | 8 | 13 | |
| 3829 | SLA2 levels | PROLV001874 | 0.39 | Protein levels | Stromal / connective | 21 | 4 | 5 | 9 | |
| 3830 | Restless legs syndrome, RLS | NEURO000012 | 0.39 | Neurologic | Neural / glial | 2 | 1 | 6 | 9 | |
| 3831 | CDKN2D levels | PROLV000383 | 0.39 | Protein levels | Platelet | 10 | 3 | 7 | 17 | |
| 3832 | COX5B/METAP1D ratio | PRORT000717 | 0.38 | Protein ratios | Hepatocyte | 10 | 3 | 9 | 12 | |
| 3833 | Mood symptoms | PSYCH000029 | 0.38 | Psychiatric | Neural / glial | 41 | 3 | 7 | 10 | |
| 3834 | SERPINE2 levels | PROLV001831 | 0.38 | Protein levels | Myeloid | 49 | 4 | 8 | 13 | |
| 3835 | PLXNA4/SPRY2 ratio | PRORT001685 | 0.38 | Protein ratios | Hepatocyte | 22 | 5 | 11 | 23 | |
| 3836 | ERBB4/UMOD ratio | PRORT001048 | 0.38 | Protein ratios | Hepatocyte | 23 | 1 | 7 | 12 | |
| 3837 | Aplastic anaemia | HEMAT000004 | 0.38 | Hematologic | Muscle / cardiac | 0 | 2 | 5 | 18 | |
| 3838 | Meniscus surgery | MSKEL000050 | 0.38 | Musculoskeletal | Lymphocyte | 2 | 2 | 6 | 23 | |
| 3839 | MAMDC2 levels | PROLV001258 | 0.38 | Protein levels | Stromal / connective | 36 | 5 | 8 | 14 | |
| 3840 | BAX levels | PROLV000180 | 0.38 | Protein levels | Vascular | 2 | 5 | 7 | 20 | |
| 3841 | AZU1/RNASE3 ratio | PRORT000186 | 0.38 | Protein ratios | Myeloid | 1 | 2 | 4 | 11 | |
| 3842 | NT5C1A levels | PROLV001439 | 0.38 | Protein levels | Muscle / cardiac | 8 | 4 | 16 | 25 | |
| 3843 | Pustular skin disorder | DERMA000018 | 0.38 | Dermatologic | Hepatocyte | 0 | 1 | 5 | 13 | |
| 3844 | OPHN1 levels | PROLV001470 | 0.38 | Protein levels | Platelet | 12 | 0 | 4 | 6 | |
| 3845 | MAVS/MED18 ratio | PRORT001495 | 0.37 | Protein ratios | Lymphocyte | 20 | 6 | 15 | 39 | |
| 3846 | Vitamin B12 deficiency anaemia | HEMAT000014 | 0.37 | Hematologic | Lymphocyte | 25 | 1 | 6 | 10 | |
| 3847 | SLIT2 levels | PROLV001887 | 0.37 | Protein levels | Neural / glial | 0 | 1 | 7 | 15 | |
| 3848 | CHRDL1 levels | PROLV000433 | 0.37 | Protein levels | B / plasma cell | 1 | 2 | 4 | 9 | |
| 3849 | CNTN3/FETUB ratio | PRORT000686 | 0.37 | Protein ratios | Hepatocyte | 37 | 1 | 7 | 10 | |
| 3850 | OXT levels | PROLV001480 | 0.37 | Protein levels | Hepatocyte | 94 | 2 | 7 | 11 | |
| 3851 | Catecholamine metabolites | METAB000070 | 0.37 | Metabolites | Vascular | 0 | 1 | 3 | 6 | |
| 3852 | ITGB1BP2/SKAP2 ratio | PRORT001387 | 0.37 | Protein ratios | Lymphocyte | 14 | 4 | 8 | 35 | |
| 3853 | HYOU1/PTPRF ratio | PRORT001314 | 0.37 | Protein ratios | Hepatocyte | 56 | 1 | 8 | 8 | |
| 3854 | PTPRC levels | PROLV001674 | 0.37 | Protein levels | Lymphocyte | 55 | 2 | 13 | 35 | |
| 3855 | Intervertebral disc disorder | MSKEL000076 | 0.37 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 3856 | TXNDC5 levels | PROLV002125 | 0.37 | Protein levels | Platelet | 15 | 2 | 6 | 20 | |
| 3857 | GOLGA3 levels | PROLV000908 | 0.36 | Protein levels | Stromal / connective | 0 | 3 | 3 | 8 | |
| 3858 | CD48/FCRL6 ratio | PRORT000464 | 0.36 | Protein ratios | Lymphocyte | 25 | 2 | 12 | 34 | |
| 3859 | Aortic valve disease | CARDI000053 | 0.36 | Cardiac | Vascular | 83 | 5 | 9 | 17 | |
| 3860 | Organic acids | METAB000068 | 0.36 | Metabolites | Neural / glial | 3 | 0 | 1 | 8 | |
| 3861 | GGACT levels | PROLV000880 | 0.36 | Protein levels | Lymphocyte | 3 | 2 | 9 | 28 | |
| 3862 | COLEC12/TGFBR2 ratio | PRORT000707 | 0.36 | Protein ratios | Hepatocyte | 75 | 3 | 8 | 18 | |
| 3863 | Fatty acids, eicosatrienoic acid | LIPID000021 | 0.36 | Lipids | Lymphocyte | 2 | 2 | 7 | 13 | |
| 3864 | REG3A levels | PROLV001719 | 0.36 | Protein levels | B / plasma cell | 29 | 1 | 8 | 10 | |
| 3865 | SMAD3 levels | PROLV001896 | 0.36 | Protein levels | Myeloid | 3 | 4 | 8 | 14 | |
| 3866 | Gut microbial abundance, Holdemania | GASTR000026 | 0.36 | Gastrointestinal | Hepatocyte | 0 | 3 | 13 | 24 | |
| 3867 | FAM177A1 levels | PROLV000764 | 0.36 | Protein levels | Gastrointestinal epithelium | 10 | 1 | 7 | 14 | |
| 3868 | PPP1R2 levels | PROLV001616 | 0.36 | Protein levels | Vascular | 8 | 4 | 8 | 19 | |
| 3869 | CEP85/ZBTB16 ratio | PRORT000604 | 0.36 | Protein ratios | Muscle / cardiac | 20 | 3 | 12 | 18 | |
| 3870 | Progesterone metabolite | METAB000072 | 0.36 | Metabolites | Hepatocyte | 13 | 1 | 6 | 18 | |
| 3871 | ATG4A levels | PROLV000159 | 0.36 | Protein levels | Vascular | 0 | 3 | 11 | 31 | |
| 3872 | LYN/SIRT2 ratio | PRORT001472 | 0.36 | Protein ratios | Lymphocyte | 5 | 1 | 5 | 11 | |
| 3873 | IGFBP6 levels | PROLV001032 | 0.35 | Protein levels | Hepatocyte | 24 | 1 | 5 | 7 | |
| 3874 | FHIT levels | PROLV000805 | 0.35 | Protein levels | Lymphocyte | 15 | 3 | 8 | 40 | |
| 3875 | Operation, cardiac | CARDI000046 | 0.35 | Cardiac | Muscle / cardiac | 20 | 2 | 5 | 7 | |
| 3876 | FKBP1B levels | PROLV000808 | 0.35 | Protein levels | Lymphocyte | 2 | 3 | 9 | 27 | |
| 3877 | DFFA levels | PROLV000615 | 0.35 | Protein levels | Stromal / connective | 1 | 3 | 10 | 13 | |
| 3878 | TPM2 levels | PROLV002095 | 0.35 | Protein levels | Hepatocyte | 9 | 3 | 10 | 17 | |
| 3879 | Hypertensive chronic kidney disease | NEPHR000002 | 0.35 | Nephrourologic | Hepatocyte | 12 | 1 | 5 | 12 | |
| 3880 | Respiratory disease | RESPI000004 | 0.35 | Respiratory | Lymphocyte | 194 | 2 | 11 | 11 | |
| 3881 | Social relationships | SOCIO000021 | 0.35 | Socioeconomic | Neural / glial | 17 | 5 | 9 | 17 | |
| 3882 | ADAMTSL5 levels | PROLV000038 | 0.35 | Protein levels | Muscle / cardiac | 9 | 4 | 6 | 14 | |
| 3883 | COL6A3/NBL1 ratio | PRORT000698 | 0.35 | Protein ratios | Stromal / connective | 29 | 2 | 2 | 8 | |
| 3884 | SHISA5 levels | PROLV001856 | 0.35 | Protein levels | Myeloid | 6 | 1 | 3 | 7 | |
| 3885 | Impacted cerumen | AUDIO000002 | 0.35 | Auditory | Salivary epithelium | 1 | 1 | 8 | 14 | |
| 3886 | Arrhythmia | CARDI000018 | 0.35 | Cardiac | Muscle / cardiac | 192 | 2 | 4 | 9 | |
| 3887 | EFNA4/TNFRSF10B ratio | PRORT000991 | 0.35 | Protein ratios | Vascular | 0 | 2 | 7 | 23 | |
| 3888 | RSPO1 levels | PROLV001758 | 0.35 | Protein levels | Vascular | 12 | 3 | 7 | 16 | |
| 3889 | BIN2 levels | PROLV000197 | 0.35 | Protein levels | Vascular | 27 | 2 | 6 | 11 | |
| 3890 | MGMT levels | PROLV001310 | 0.35 | Protein levels | Myeloid | 10 | 4 | 7 | 14 | |
| 3891 | BCR/DECR1 ratio | PRORT000223 | 0.35 | Protein ratios | Hepatocyte | 2 | 2 | 9 | 31 | |
| 3892 | ART3 levels | PROLV000147 | 0.35 | Protein levels | Muscle / cardiac | 82 | 2 | 6 | 7 | |
| 3893 | DOK2/SNX9 ratio | PRORT000943 | 0.35 | Protein ratios | Hepatocyte | 22 | 3 | 7 | 18 | |
| 3894 | GFRAL levels | PROLV000879 | 0.35 | Protein levels | Vascular | 26 | 2 | 9 | 20 | |
| 3895 | ASPSCR1 levels | PROLV000154 | 0.35 | Protein levels | Vascular | 0 | 0 | 3 | 9 | |
| 3896 | TNFRSF10B levels | PROLV002058 | 0.34 | Protein levels | Myeloid | 21 | 0 | 3 | 2 | |
| 3897 | ANXA4/FADD ratio | PRORT000110 | 0.34 | Protein ratios | Hematopoietic progenitor | 0 | 1 | 4 | 9 | |
| 3898 | FCRL2/TNFRSF13B ratio | PRORT001132 | 0.34 | Protein ratios | B / plasma cell | 10 | 3 | 8 | 18 | |
| 3899 | PRKG1 levels | PROLV001633 | 0.34 | Protein levels | Stromal / connective | 10 | 4 | 7 | 15 | |
| 3900 | GRAP2/SRC ratio | PRORT001246 | 0.34 | Protein ratios | Lymphocyte | 10 | 2 | 7 | 13 | |
| 3901 | NAA80 levels | PROLV001368 | 0.34 | Protein levels | Vascular | 9 | 3 | 6 | 11 | |
| 3902 | CXCL3 levels | PROLV000583 | 0.34 | Protein levels | Stromal / connective | 18 | 2 | 5 | 5 | |
| 3903 | ICAM3/NOTCH1 ratio | PRORT001327 | 0.34 | Protein ratios | Hepatocyte | 22 | 2 | 9 | 23 | |
| 3904 | CDH5 levels | PROLV000376 | 0.34 | Protein levels | Vascular | 33 | 3 | 9 | 25 | |
| 3905 | LATS1 levels | PROLV001186 | 0.34 | Protein levels | Myeloid | 4 | 3 | 6 | 16 | |
| 3906 | MIF/SUSD2 ratio | PRORT001535 | 0.34 | Protein ratios | Vascular | 33 | 1 | 7 | 22 | |
| 3907 | GGT5 levels | PROLV000884 | 0.34 | Protein levels | Hepatocyte | 21 | 1 | 8 | 12 | |
| 3908 | Microscopic colitis | IMMUN000033 | 0.34 | Immunologic | Muscle / cardiac | 7 | 1 | 4 | 12 | |
| 3909 | Ischaemic stroke | VASCU000015 | 0.34 | Vascular | Muscle / cardiac | 4 | 3 | 8 | 13 | |
| 3910 | Atrioventricular block | CARDI000028 | 0.34 | Cardiac | Muscle / cardiac | 7 | 4 | 6 | 19 | |
| 3911 | COL28A1 levels | PROLV000487 | 0.34 | Protein levels | B / plasma cell | 11 | 0 | 4 | 14 | |
| 3912 | Estradiol | ENDOC000006 | 0.34 | Endocrine | Hepatocyte | 16 | 3 | 9 | 17 | |
| 3913 | ARHGEF12 levels | PROLV000141 | 0.34 | Protein levels | Hepatocyte | 17 | 1 | 6 | 14 | |
| 3914 | FADD levels | PROLV000758 | 0.34 | Protein levels | Stromal / connective | 13 | 3 | 5 | 15 | |
| 3915 | CCN4 levels | PROLV000304 | 0.34 | Protein levels | Platelet | 32 | 1 | 3 | 6 | |
| 3916 | IL10RB levels | PROLV001043 | 0.34 | Protein levels | Granulosa cell | 21 | 1 | 8 | 7 | |
| 3917 | Social support | SOCIO000022 | 0.33 | Socioeconomic | Neural / glial | 21 | 5 | 9 | 15 | |
| 3918 | LYN/YES1 ratio | PRORT001474 | 0.33 | Protein ratios | Hepatocyte | 6 | 2 | 8 | 19 | |
| 3919 | AMBP/EFEMP1 ratio | PRORT000085 | 0.33 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 11 | |
| 3920 | GPC5 levels | PROLV000920 | 0.33 | Protein levels | Myeloid | 71 | 2 | 9 | 20 | |
| 3921 | Hepatomegaly | HPBIL000022 | 0.33 | Hepatopancreatobiliary | Hepatocyte | 12 | 3 | 9 | 19 | |
| 3922 | ANG levels | PROLV000092 | 0.33 | Protein levels | Hepatocyte | 66 | 1 | 5 | 7 | |
| 3923 | Dorsopathy | MSKEL000075 | 0.33 | Musculoskeletal | Stromal / connective | 14 | 2 | 7 | 22 | |
| 3924 | SORCS2 levels | PROLV001919 | 0.33 | Protein levels | Neural / glial | 6 | 1 | 7 | 5 | |
| 3925 | Medication, benign prostatic hyperplasia | REPRO000017 | 0.33 | Reproductive | Respiratory epithelium | 14 | 0 | 4 | 4 | |
| 3926 | NT5C levels | PROLV001438 | 0.33 | Protein levels | Lymphocyte | 34 | 2 | 8 | 33 | |
| 3927 | Cancer, Breast | MALIG000011 | 0.33 | Malignancy | Cutaneous epithelium | 47 | 1 | 8 | 13 | |
| 3928 | Handedness | BEHAV000003 | 0.33 | Behavioural | Neural / glial | 0 | 5 | 14 | 31 | |
| 3929 | CCN3 levels | PROLV000303 | 0.33 | Protein levels | Vascular | 8 | 1 | 4 | 10 | |
| 3930 | PSME2 levels | PROLV001659 | 0.33 | Protein levels | Vascular | 1 | 4 | 9 | 30 | |
| 3931 | Supplement use, mineral or vitamin, none | DTSUP000027 | 0.33 | Diet and Supplement | Neural / glial | 2 | 5 | 8 | 19 | |
| 3932 | NADK/PXN ratio | PRORT001570 | 0.33 | Protein ratios | Granulosa cell | 0 | 1 | 5 | 5 | |
| 3933 | CD27/ICAM3 ratio | PRORT000414 | 0.33 | Protein ratios | B / plasma cell | 33 | 0 | 4 | 7 | |
| 3934 | Intelligence decline | PSYCH000005 | 0.33 | Psychiatric | Lymphocyte | 0 | 4 | 10 | 39 | |
| 3935 | SLC9A3R1 levels | PROLV001885 | 0.33 | Protein levels | Myeloid | 7 | 4 | 9 | 17 | |
| 3936 | AOC3/ITGB1 ratio | PRORT000113 | 0.33 | Protein ratios | Stromal / connective | 16 | 3 | 14 | 10 | |
| 3937 | Water consumption | DTSUP000004 | 0.33 | Diet and Supplement | Neural / glial | 104 | 3 | 4 | 14 | |
| 3938 | Pre-eclampsia | VASCU000047 | 0.33 | Vascular | Myeloid | 7 | 2 | 3 | 7 | |
| 3939 | REN levels | PROLV001723 | 0.32 | Protein levels | Neural / glial | 2 | 0 | 3 | 8 | |
| 3940 | TYRO3 levels | PROLV002129 | 0.32 | Protein levels | Lymphocyte | 36 | 1 | 9 | 30 | |
| 3941 | SMTN levels | PROLV001904 | 0.32 | Protein levels | Myeloid | 2 | 1 | 1 | 7 | |
| 3942 | MESD/WWP2 ratio | PRORT001519 | 0.32 | Protein ratios | Hepatocyte | 0 | 4 | 13 | 18 | |
| 3943 | SH2B3/TBL1X ratio | PRORT001784 | 0.32 | Protein ratios | Lymphocyte | 1 | 3 | 18 | 26 | |
| 3944 | SPART levels | PROLV001925 | 0.32 | Protein levels | Platelet | 10 | 5 | 10 | 19 | |
| 3945 | Peripheral nerve disorder | NEURO000031 | 0.32 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 3946 | SEMA4D/TXNDC5 ratio | PRORT001772 | 0.32 | Protein ratios | Stromal / connective | 0 | 3 | 6 | 14 | |
| 3947 | PITHD1 levels | PROLV001563 | 0.32 | Protein levels | Vascular | 0 | 1 | 6 | 10 | |
| 3948 | Papulosquamous disorder | DERMA000015 | 0.32 | Dermatologic | Lymphocyte | 65 | 2 | 12 | 14 | |
| 3949 | DLL1/TGFBR2 ratio | PRORT000919 | 0.32 | Protein ratios | Vascular | 20 | 0 | 3 | 2 | |
| 3950 | ATG4A/TPMT ratio | PRORT000150 | 0.32 | Protein ratios | Neural / glial | 0 | 3 | 7 | 13 | |
| 3951 | DNPH1/PDGFB ratio | PRORT000936 | 0.32 | Protein ratios | Hepatocyte | 5 | 4 | 7 | 23 | |
| 3952 | AMBP/HYOU1 ratio | PRORT000087 | 0.31 | Protein ratios | Hepatocyte | 91 | 2 | 6 | 9 | |
| 3953 | Medication use | MISCL000037 | 0.31 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 3954 | NEFL levels | PROLV001389 | 0.31 | Protein levels | Hepatocyte | 16 | 2 | 7 | 16 | |
| 3955 | CIRBP levels | PROLV000437 | 0.31 | Protein levels | Myeloid | 8 | 2 | 6 | 15 | |
| 3956 | NSFL1C levels | PROLV001437 | 0.31 | Protein levels | Vascular | 9 | 1 | 8 | 21 | |
| 3957 | GORASP2 levels | PROLV000911 | 0.31 | Protein levels | Vascular | 13 | 2 | 7 | 27 | |
| 3958 | Hand grip strength | MSKEL000030 | 0.31 | Musculoskeletal | Stromal / connective | 131 | 5 | 7 | 13 | |
| 3959 | CLEC14A/PIK3IP1 ratio | PRORT000627 | 0.31 | Protein ratios | Vascular | 6 | 2 | 9 | 14 | |
| 3960 | PLPBP levels | PROLV001580 | 0.31 | Protein levels | Lymphocyte | 16 | 2 | 8 | 31 | |
| 3961 | ENO2/SCRN1 ratio | PRORT001030 | 0.31 | Protein ratios | Hematopoietic progenitor | 1 | 1 | 2 | 4 | |
| 3962 | Arterial stiffness | VASCU000050 | 0.31 | Vascular | Stromal / connective | 3 | 2 | 3 | 12 | |
| 3963 | CST3 levels | PROLV000549 | 0.31 | Protein levels | Renal epithelium | 1,140 | 0 | 3 | 6 | |
| 3964 | TNFAIP8 levels | PROLV002055 | 0.30 | Protein levels | Muscle / cardiac | 0 | 2 | 5 | 11 | |
| 3965 | BTN3A2 levels | PROLV000220 | 0.30 | Protein levels | Lymphocyte | 122 | 3 | 11 | 23 | |
| 3966 | CDHR1 levels | PROLV000378 | 0.30 | Protein levels | Muscle / cardiac | 0 | 4 | 11 | 24 | |
| 3967 | TP53BP1 levels | PROLV002090 | 0.30 | Protein levels | B / plasma cell | 66 | 2 | 10 | 28 | |
| 3968 | Cardiovascular age gap | CARDI000001 | 0.30 | Cardiac | Muscle / cardiac | 27 | 3 | 6 | 16 | |
| 3969 | Pregnancy complication, preterm labour | REPRO000034 | 0.30 | Reproductive | Lymphocyte | 0 | 2 | 17 | 25 | |
| 3970 | Citrulline | METAB000020 | 0.30 | Metabolites | Muscle / cardiac | 0 | 1 | 6 | 5 | |
| 3971 | EGF/MGLL ratio | PRORT000996 | 0.30 | Protein ratios | Vascular | 11 | 3 | 8 | 27 | |
| 3972 | OTUD7B levels | PROLV001478 | 0.30 | Protein levels | Muscle / cardiac | 2 | 4 | 6 | 14 | |
| 3973 | Hypertrophic and atrophic skin condition | DERMA000040 | 0.30 | Dermatologic | Melanocyte | 9 | 1 | 4 | 9 | |
| 3974 | Testicular disorder | REPRO000015 | 0.30 | Reproductive | Adipose | 8 | 1 | 8 | 13 | |
| 3975 | LGMN/SPINT2 ratio | PRORT001457 | 0.30 | Protein ratios | Platelet | 0 | 1 | 5 | 7 | |
| 3976 | Kidney volume | NEPHR000022 | 0.30 | Nephrourologic | Stromal / connective | 1 | 3 | 8 | 25 | |
| 3977 | MINK1 levels | PROLV001316 | 0.30 | Protein levels | Stromal / connective | 2 | 4 | 6 | 15 | |
| 3978 | Thyroid disorder | ENDOC000023 | 0.29 | Endocrine | Lymphocyte | 189 | 1 | 10 | 25 | |
| 3979 | FLRT2/GFRA3 ratio | PRORT001161 | 0.29 | Protein ratios | Granulosa cell | 18 | 2 | 10 | 21 | |
| 3980 | NCK2 levels | PROLV001381 | 0.29 | Protein levels | Stromal / connective | 13 | 3 | 7 | 16 | |
| 3981 | MINPP1 levels | PROLV001317 | 0.29 | Protein levels | Neural / glial | 0 | 5 | 15 | 23 | |
| 3982 | Sugar alcohols | METAB000037 | 0.29 | Metabolites | Vascular | 0 | 1 | 4 | 12 | |
| 3983 | Telomere length | AGING000001 | 0.29 | Aging | Hematopoietic progenitor | 228 | 2 | 10 | 22 | |
| 3984 | F2R/SNX9 ratio | PRORT001082 | 0.29 | Protein ratios | Lymphocyte | 7 | 2 | 13 | 26 | |
| 3985 | AIDA levels | PROLV000067 | 0.29 | Protein levels | B / plasma cell | — | 2 | 5 | 25 | |
| 3986 | DAPP1/PMVK ratio | PRORT000855 | 0.29 | Protein ratios | Muscle / cardiac | 1 | 2 | 4 | 10 | |
| 3987 | Stroke | VASCU000017 | 0.29 | Vascular | Vascular | 37 | 2 | 4 | 11 | |
| 3988 | ARHGEF5 levels | PROLV000142 | 0.29 | Protein levels | Lymphocyte | 8 | 0 | 3 | 13 | |
| 3989 | CNPY4 levels | PROLV000473 | 0.29 | Protein levels | Neural / glial | 24 | 6 | 10 | 14 | |
| 3990 | AFP levels | PROLV000053 | 0.29 | Protein levels | Hepatocyte | 177 | 1 | 5 | 7 | |
| 3991 | RGMA levels | PROLV001728 | 0.29 | Protein levels | Muscle / cardiac | 126 | 1 | 7 | 11 | |
| 3992 | PGF levels | PROLV001544 | 0.29 | Protein levels | Vascular | 24 | 1 | 4 | 14 | |
| 3993 | ALCAM/CDH5 ratio | PRORT000068 | 0.29 | Protein ratios | Hepatocyte | 26 | 1 | 8 | 15 | |
| 3994 | Knee extension strength | MSKEL000031 | 0.29 | Musculoskeletal | Stromal / connective | 0 | 2 | 6 | 10 | |
| 3995 | RRAS levels | PROLV001755 | 0.28 | Protein levels | Lymphocyte | 9 | 2 | 6 | 14 | |
| 3996 | WFDC5 levels | PROLV002190 | 0.28 | Protein levels | Hepatocyte | 0 | 2 | 9 | 11 | |
| 3997 | Electrolyte disorder | METBL000004 | 0.28 | Metabolic | Hepatocyte | 5 | 0 | 5 | 10 | |
| 3998 | SUMF1 levels | PROLV001975 | 0.28 | Protein levels | Lymphocyte | 0 | 4 | 12 | 28 | |
| 3999 | HS6ST1/MEGF9 ratio | PRORT001301 | 0.28 | Protein ratios | Hepatocyte | 86 | 2 | 6 | 7 | |
| 4000 | UPB1 levels | PROLV002142 | 0.28 | Protein levels | Hepatocyte | 31 | 1 | 5 | 11 |